To easily search for a policy, use the Ctrl+F (Command+F on Mac) function on your keyboard to search by keyword, policy number or effective date. 

What are Clinical Policies?

Clinical policies are one set of guidelines used to assist in administering health plan benefits, either by prior authorization or payment rules. They include policies relating to evolving medical technologies and procedures as well as pharmacy policies. Clinical policies help identify whether services are medically necessary based on information found in generally accepted standards of medical practice, including peer-reviewed medical literature, government agency/program approval status, evidence-based guidelines, positions of leading national health professional organizations, views of physicians practicing in relevant clinical areas affected by the policy, and other available clinical information.

All policies found on the QualChoice Clinical Policy page apply to QualChoice members. Policies on this QualChoice page may have either a “QualChoice” or a “Centene” heading. QualChoice follows care guidelines published by InterQual.
QualChoice may, from time to time, delegate utilization management of specific services. In such circumstances, the delegated vendor’s guidelines may also be used to support medical necessity and other coverage determinations. Other non-clinical policies (e.g., payment policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in the policies on this page or within the InterQual criteria is payable by QualChoice.

QualChoice reserves the right to alter, amend, change or supplement medical policies as needed. QualChoice reviews and authorizes services and substances. CPT and HCPCS codes are listed as a convenience and any absent, new or changed codes do not alter the intent of the policy.

What are Payment Policies?

Healthcare claims payment policies are guidelines used to assist in administering payment rules based on generally accepted principles of correct coding. They are used to help identify whether healthcare services are correctly coded for reimbursement. Each payment rule is sourced by a generally accepted coding principle. They include claims processing guidelines referenced by the Centers for Medicare & Medicaid Services (CMS), Publication 100-04, Claims Processing Manual for physicians/non-physician practitioners, the CMS National Correct Coding Initiative policy manual (procedure-to-procedure coding combination edits and medically unlikely edits), CPT® guidance published by the American Medical Association (AMA) for reporting medical procedures and services, health plan clinical policies based on the appropriateness of healthcare and medical necessity, ClaimsXten™ review, and, at times, state-specific claims reimbursement guidance. More information about ClaimsXten and the way we utilize ClaimsXten with relation to claims payments can be found on our Claims and Payment Information page.

All policies found on this page apply with respect to QualChoice members. These payment policies may have either a “QualChoice” or a “Centene” heading. QualChoice may, from time-to-time, employ a vendor that applies payment policies to specific services. In such circumstances, the vendor’s guidelines may also be used to determine whether a service has been correctly coded. Other policies (e.g., clinical policies) or contract terms may further determine whether a technology, procedure, or treatment that is not addressed in these policies is payable by QualChoice.

Clinical Policies for CT/CTA/CCTA, MRI, MRA, and Pet scans can also be found at the Evolent website.

   
Policy Title Policy Number Effective Date
25-hydroxyvitamin D Testing in Children and Adolescents (PDF) CP.MP.157 November 1, 2024
ABI (subacute and chronic) inpatient neurorehabilitation (PDF) AR.CP.MP.501 October 1, 2025
Air Ambulance (PDF)

CP.MP.175 May 1, 2025
Allergy Testing & Treatment (PDF) CP.MP.100 November 1, 2024
Allogeneic Hematopoietic Cell Transplants for Sickle Cell Anemia and β-Thalassemia (PDF) CP.MP.108 October 1, 2025
Applied Behavior Analysis (PDF) CP.BH.104 June 1. 2025
Applied Behavioral Analysis Documentation Requirements (PDF) CP.BH.105 June 1, 2025
Assisted Reproductive Technology (PDF) CP.MP.55 July 1, 2025
Attention Deficit Hyperactivity Disorder Assessment and Treatment (PDF) CP.BH.124 May 1, 2024
Bariatric Surgery (PDF) CP.MP.37 June 1, 2025
Bariatric Surgery: Federal Employees Health Benefits (PDF) QCP.CP.029 November 1, 2025
Behavioral Health Treatment Documentation Requirements (PDF) CP.BH.500 August 1, 2025
Biofeedback (PDF) CP.MP.168 February 1, 2025
Biofeedback for Behavioral Health Disorders (PDF) CP.BH.300 July 1, 2025
Bone-Anchored Hearing Aids (PDF) AR.CP.MP.93 November 1, 2025
Burn Surgery (PDF) CP.MP.186 February 1, 2025
Cardiac Biomarker Testing (PDF) CP.MP.156 November 1, 2024
Caudal or Interlaminar Epidural Steroid Injections (PDF) CP.MP.164 July 1, 2025
Clinical Trials (PDF) CP.MP.94 August 1, 2025
Cochlear Implanted Replacements (PDF) AR.CP.MP.14 July 1, 2025
Corneal Hysteresis (PDF) CP.VP.17 October 1, 2025
Corneal Topography (PDF) CP.VP.18 October 1, 2025
V1.2025 - CG Oncology: Algorithmic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Cancer Screening AR Specific Version (PDF) V1.2025  April 1, 2025
V1.2025 - CG Oncology: Circulating Tumor DNA and Circulating Tumor Cells (Liquid Biopsy) (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Cytogenetic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Oncology: Molecular Analysis of Solid Tumors and Hematologic Malignancies (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Aortopathies and Connective Tissue Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Cardiac Disorders (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Dermatologic Conditions (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Epilepsy, Neurodegenerative, and Neuromuscular Conditions (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Exome and Genome Sequencing for the Diagnosis of Genetic Disorders (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: Eye Disorders (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: Gastroenterologic Disorders Non-Cancerous (PDF) V1.2025   April 1, 2025
V1.2025 - CG Testing: General Approach to Genetic and Molecular Testing (PDF) V1.2025  April 1, 2025
V1.2025 - CG Testing: Hearing Loss (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Hematologic Conditions Non-Cancerous (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Hereditary Cancer Susceptibility (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Immune, Autoimmune, and Rheumatoid Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Kidney Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Lung Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Metabolic, Endocrine, and Mitochondrial Disorders (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Multisystem Inherited Disorders, Intellectual Disability, and Developmental Delay (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal Cell-Free DNA Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Pharmacogenetics (Version B) (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Preimplantation Genetic Testing (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal and Preconception Carrier Screening (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Prenatal Diagnosis (via Amniocentesis, CVS, or PUBS) and Pregnancy Loss (PDF) V1.2025 April 1, 2025
V1.2025 - CG Testing: Skeletal Dysplasia and Rare Bone Disorders (PDF) V1.2025 April 1, 2025
Corneal Remodeling (f.n.a. Refractive Surgical Procedures) (PDF) QCP.CP.021 November 1, 2025
Cosmetic and Reconstructive Procedures (PDF) CP.MP.31 October 1, 2025
Deep Transcranial Magnetic Stimulation for the Treatment of Obsessive Compulsive Disorder (PDF) CP.BH.201 July 1, 2025
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)  CP.PCH.56  October 1, 2025
Diaphragmatic/Phrenic Nerve Stimulation (PDF) CP.MP.203 September 1, 2025
Digital EEG Spike Analysis (PDF) CP.MP.105 November 1, 2024
Disc Decompression Procedures (PDF) CP.MP.114 June 1, 2025
Discography (PDF) CP.MP.115 June 1, 2024
Donor Lymphocyte Infusion (PDF) CP.MP.101 April 1, 2025
Drugs of Abuse, Definitive Testing (PDF) CP.MP.50 May 1, 2025
Durable Medical Equipment and Orthotics Guidelines (PDF) AR.CP.MP.107 May 1, 2025
EED in the Evaluation of Headache (PDF) CP.MP.155 November 1, 2024
Electric Tumor Treating Fields (Optune) (PDF) CP.MP.145 March 1, 2025
Electroretinography (PDF) CP.VP.86 October 1, 2025
Endometrial Ablation (PDF) CP.MP.106 November 1, 2024
Evoked Potential Testing (PDF) CP.MP.134 November 1, 2024
Experimental Technologies (PDF) CP.MP.36 October 1, 2025
Extended Ophthalmoscopy (PDF) CP.VP.26 October 1, 2025
External Ocular Photography (PDF) CP.VP.43 October 1, 2025
Facet Joint Interventions (PDF) CP.MP.171 July 1, 2025
Facility-based Sleep Studies for Obstructive Sleep Apnea (PDF) CP.MP.248 March 1, 2025
Fecal Incontinence Treatments (PDF) CP.MP.137 October 1, 2025
FEHB Fertility Preservation (PDF) QCP.CP.042 November 1, 2025
FEHBP Gender Reassignment Surgery (PDF) QCP.CP.037 November 1, 2025
FEHB Infertility Coverage (PDF) QCP.CP.027 November 1, 2025
Fetal Surgery in Utero for Prenatally Diagnosed Malformations (PDF) CP.MP.129 July 1, 2025
Ferriscan R2-MRI (PDF) CP.MP.53 May 1, 2024
Fluorescein Angiography (PDF) CP.VP.28 October 1, 2025
Fundus Photography (PDF) CP.VP.29 October 1, 2025
Gastric Electrical Stimulation (PDF) CP.MP.40 June 1, 2024
Gastrointestinal Pathogen Nucleic Acid Detection Panel Testing (PDF) CP.MP.209 May 1, 2024
Gender Affirming Procedures (PDF) CP.MP.95 September 1, 2024
Gonioscopy (PDF) CP.VP.31 October 1, 2025
H. Pylori Serology Testing (PDF) CP.MP.153 November 1, 2024
Heart-Lung Transplant (PDF) CP.MP.132 July 1, 2025
Holter Monitors (PDF) CP.MP.113 May 1, 2025
Home Births (PDF) CP.MP.136 June 1, 2025
Home Ventilators (PDF)  AR.CP.MP.184 August 1, 2025
Homocysteine Testing (PDF) CP.MP.121 May 1, 2025
Hospice Services (PDF) CP.MP.54 August 1, 2025
Hyperhidrosis Treatments (PDF) CP.MP.62 May 1, 2025
Implantable Hypoglossal Nerve Stim (PDF) CP.MP.180 August 1, 2025
Implantable Intrathecal or Epidural Pain Pump (PDF) CP.MP.173 February 1, 2025
Implantable Loop Recorder (PDF) CP.MP.243 February 1, 2025
Implantable Wireless Pulmonary Artery Pressure Monitoring (PDF) CP.MP.160 April 1, 2025
Infertility Diagnosis and Treatment (PDF) QCP.CP.015 November 1, 2025
Intensity-Modulated Radiotherapy (PDF) CP.MP.69 July 1, 2025
Intestinal and Multivisceral Transplant (PDF) CP.MP.58 July 1, 2024
Intradiscal Steroid Injections for Pain Management (PDF) CP.MP.167 September 1, 2025
Intraoperative Neurophysiological Monitoring (PDF) QCP.CP.033 November 1, 2025
IV Moderate Sedation, IV Deep Sedation, and General Anesthesia for Dental Procedures (PDF) CP.MP.61 October 1, 2024
Lantidra (donislecel) Allogenic Pancreatic Islet Cellular Therapy (PDF) CP.MP.250 September 1, 2025
Liposuction for Lipedema (PDF) CP.MP.244 June 1, 2025
Lung Transplantation (PDF) CP.MP.57 July 1, 2025
Lysis of Epidural Lesions (PDF) CP.MP.116 June 1, 2025
Measurement of Serum 1,25-dihydroxyvitamin D (PDF) CP.MP.152 November 1, 2024
Mechanical Stretch devices for joint stiffness or contractures (PDF) CP.MP.144 May 1, 2025
Medically Necessary Hardware (PDF) CP.VP.06 October 1, 2025
Medical Services that Require Dental Services (PDF) QCP.CP.030 May 1, 2024
Multiple Sleep Latency Testing (PDF) CP.MP.24 September 1, 2025
Neonatal Abstinence Syndrome Guidelines (PDF) CP.MP.86 August 1, 2025
Neonatal Sepsis Management Guidelines (PDF) CP.MP.85 August 1, 2025
Nerve Blocks for Pain Management (PDF) CP.MP.170 April 1, 2025
Neuromuscular and Peroneal Nerve Electrical Stimulation (NMES) (PDF) CP.MP.48 July 1, 2025
NICU Apnea Bradycardia Guidelines (PDF) CP.MP.82 August 1, 2025
NICU Discharge Guidelines (PDF) CP.MP.81 August 1, 2025
Nonmyeloablative Allogeneic Stem Cell Transplants (PDF) CP.MP.141 May 1, 2024
Obstetrical Home Care Programs (PDF) CP.MP.91 February 1, 2025
Omisirge (omidubicel): Nicotinamide-modified allogeneic hematopoietic progenitor cell therapy (PDF) CP.MP.249 October 1, 2025
Opthalmic Biometry (PDF) CP.VP.45 October 1, 2025
Orthognathic Surgery (PDF) CP.MP.202  January 1, 2026
Osteogenic Stimulation (PDF) CP.MP.194 August 1, 2025
Pancreas Transplantation (PDF) CP.MP.102 June 1, 2024
Panniculectomy (PDF) CP.MP.109 October 1, 2025
Pediatric Heart Transplant (PDF) CP.MP.138 October 1, 2025
Pediatric Kidney Transplant (PDF) CP.MP.246 April 1, 2025
Pediatric Liver Transplant (PDF) CP.MP.120 July 1, 2025
Pediatric Oral Function Therapy (PDF) CP.MP.188 June 1, 2025
Percutaneous Left Atrial Appendage Closure Device for Stroke Prevention (PDF) CP.MP.147 August 1, 2025
Phototherapy for Neonatal Hyperbilirubinemia (PDF) CP.MP.150 August 1, 2025
Physical, Occupational, and Speech Therapy Services (PDF) CP.MP.49 November 1, 2025
PPO Infertility Treatment (PDF) QCP.CP.031 May 1, 2024
Polymerase Chain Reaction Respiratory Viral Panel Testing (PDF) CP.MP.181 May 1, 2025
Posterior Tibial Nerve Stimulation for Voiding Dysfunction (PDF) CP.MP.133 September 1, 2025
Prosthetics (PDF) QCP.CP.028 November 1, 2025
Proton and Neutron Beam Therapies (PDF) CP.MP.70 May 1, 2025
PPO In Vitro Fertilization (PDF) AR.QC.CP.031 July 1, 2024
Reduction Mammoplasty and Gynecomastia Surgery (PDF) CP.MP.51 November 1, 2024
Radiation Therapy for Skin Cancer CP.MP.251  October 1, 2025
Repair of Nasal Valve Compromise (PDF) CP.MP.210 June 1, 2025
Sacroiliac Joint Fusion (PDF) CP.MP.126 June 1, 2025
Sacroiliac Joint Interventions for Pain Management (PDF) CP.MP.166 September 1, 2024
Scanning Computerized Ophthalmic Diagnostic Imaging (PDF) CP.VP.14 October 1, 2025
Sclerotherapy and Chemical Endovenous Ablation for Varicose Veins and Other Symptomatic Venous Disorders (PDF) CP.MP.146 May 1, 2025
Selective Dorsal Rhizotomy for Spasticity in Cerebral Palsy (PDF) CP.MP.174 February 1, 2025
Selective Nerve Root Blocks and Transforaminal Epidural Steroid Injections (PDF) CP.MP.165 September 1, 2024
Serial Tonometry (PDF) CP.VP.74 October 1, 2025
Skin and Soft Tissue Substitutes for Chronic Wounds (PDF) CP.MP.185 November 1, 2025
Spinal Cord, Peripheral Nerve, and Percutaneous Electrical Nerve Stimulation (PDF) CP.MP.117 February 1, 2025
Stereotactic Body Radiation Therapy (PDF) CP.MP.22 December 1, 2024
Substance Use Disorders Treatment and Services (PDF) CP.BH.100 May 1, 2024
Tandem Transplant (PDF) CP.MP.162 June 1, 2024
Testing for Select Genitourinary Conditions (PDF) CP.MP.97 May 1, 2025
Teleretinal Screening for diabetic retinopathy (PDF) CP.VP.88 October 1, 2025
Therapeutic Utilization of Inhaled Nitric Oxide (PDF) CP.MP.87 February 1, 2025
Thyroid Hormones and Insulin Testing in Pediatrics (PDF) CP.MP.154 November 1, 2024
Total Artificial Heart (PDF) CP.MP.127 October 1, 2025
Total Parenteral Nutrition and Intradialytic Parenteral Nutrition (PDF) CP.MP.163 June 1, 2025
Transplant Service Documentation Requirements (PDF) CP.MP.247 September 1, 2025
Transcranial Magnetic Stimulation for Treatment Resistant Major Depression (PDF) CP.BH.200 July 1, 2025
Trigger Point Injections for Pain Management (PDF) CP.MP.169 September 1, 2025
Urinary Incontinence Devices and Treatments (PDF) CP.MP.142 May 1, 2025
Vagus Nerve Stimulation (PDF) CP.MP.12 September 1, 2025
Ventricular Assist Devices (PDF) CP.MP.46 February 1, 2025
Visual Field Testing (PDF) CP.VP.63 October 1, 2025
Wireless Motility Capsule (PDF) CP.MP.143 November 1, 2024
Policy Title Policy Number Effective Date
3-Day Payment Window (PDF) CC.PP.500 May 1, 2024
Add-On Code Billed Without Primary Code (PDF) CC.PP.030 May 1, 2024
Ambulatory EEG (PDF) CP.MP.96 May 1, 2024
Assistant Surgeon (PDF) CC.PP.029 May 1, 2024
Bronchial Thermoplasty (PDF) CP.MP.110 November 1, 2023
Clean Claims (PDF) CC.PP.021 May 1, 2024
Coding Overview (PDF) CC.PP.011 May 1, 2024
Cosmetic Procedures (PDF) CC.PP.024 May 1, 2024
E&M Medical Decision-Making (PDF) CC.PP.051 May 1, 2024
Emergency Department Care QCP.PP.040 May 1, 2024
Global Maternity Billing (PDF) CC.PP.016 May 1, 2024
Hospice Services (PDF) CP.MP.54 May 1, 2024
Inpatient Consultation (PDF) CC.PP.038 May 1, 2024
Inpatient Only Procedures (PDF) MP.PP.018 May 1, 2024
Laser Therapy for Skin Conditions (PDF) CP.MP.123 November 1, 2024
Low-frequency Ultrasound and Noncontact Normothermic Wound Therapy (PDF) CP.MP.139 November 1, 2024
Maximum Units (PDF) CC.PP.007 May 1, 2024
Moderate Conscious Sedation (PDF) CC.PP.015 May 1, 2024
Modifier DOS Validation (PDF) CC.PP.034 May 1, 2024
Modifier to Procedure Code Validation (PDF) CC.PP.028 May 1, 2024
Multiple CPT Code Replacement (PDF) CC.PP.033 May 1, 2024
NCCI Unbundling (PDF) CC.PP.031 May 1, 2024
Never Paid Events (PDF) CC.PP.017 May 1, 2024
Non Face-to-Face Services (PDF) QCP.PP.017 May 1, 2024
Outpatient Consultation (PDF) CC.PP.039 May 1, 2024
Pediatric Dental (PDF) QCP.PP.036 May 1, 2024
Physician Extenders (PDF) QCP.PP.032 May 1, 2024
Place of Service Mismatch (PDF) CC.PP.063  May 1, 2024
Platelet Rich Plasma (PDF) QCP.PP.010 May 1, 2024
Post-Operative Visits (PDF) CC.PP.042 May 1, 2024
Pre-Operative Visits (PDF) CC.PP.041 May 1, 2024
Problem Oriented Visits with Preventative Services (PDF) CC.PP.057 May 1, 2024
Prolonged Medical Services (PDF) QCP.PP.013 May 1, 2024
Pulmonary Function Testing (PDF) CP.MP.242 November 1, 2024
Pulse Oximetry (PDF) CC.PP.025 May 1, 2024
Robotic Surgery (PDF) CC.PP.050 May 1, 2024
Routine & Complex Office Procedures (PDF) QCP.PP.025 May 1, 2024
Same Day Visits (PDF) CC.PP.040 May 1, 2024
Severe Malnutrition (PDF) CC.PP.145 November 1, 2024
Skilled Nursing Facility Leveling (PDF) CC.PP.206 May 1, 2025
Status "B" Bundled Services (PDF) CC.PP.046 May 1, 2024
Status P Bundled Services (PDF) CC.PP.049 May 1, 2024
Supplies Billed on Same Day As Surgery (PDF) CC.PP.032 May 1, 2024
Transgender Related Services (PDF) CC.PP.047 May 1, 2024
Ultrasound in Pregnancy (PDF) CP.MP.38 November 1, 2024
Unbundled Professional Services (PDF) CC.PP.043 May 1, 2024
Unlisted Procedure Codes (PDF) CC.PP.009 May 1, 2024
Urine Specimen Validity Testing (PDF) CC.PP.056 May 1, 2024
Urodynamic Testing (PDF) CP.MP.98 November 1, 2024
 
Policy Title Policy Number Effective Date
Abaloparatide (Tymlos) (PDF)   CP.PHAR.345   October 1, 2025
Abatacept (Orencia) (PDF) CP.PHAR.241 January 1, 2025
Abemaciclib (Verzenio) (PDF) CP.PHAR.355 Version effective until March 1, 2026
Abemaciclib (Verzenio) (PDF) CP.PHAR.355 March 1, 2026
Abiraterone (Zytiga) (PDF)  CP.PHAR.84  April 1, 2025
AbobotulinumtoxinA (Dysport) (PDF)   CP.PHAR.230   October 1, 2025
Abrocitinib (Cibinqo) (PDF)  CP.PHAR.578  Version effective until March 1, 2026
Abrocitinib (Cibinqo) (PDF)  CP.PCH.57 March 1, 2026
Acalabrutinib (Calquence) (PDF)  CP.PHAR.366 June 1, 2025
Aceclidine (Vizz) (PDF) CP.PMN.302 March 1, 2026
Acoltremon (Tryptyr) (PDF) CP.PHAR.739 October 1, 2025
Acoramidis (Attruby) (PDF)  CP.PHAR.683  October 1, 2025
Acyclovir Buccal tab (Sitavig) (PDF) CP.PMN.210 December 1, 2025
Adagrasib (Krazati) (PDF)   CP.PHAR.605   October 1, 2025
ADAMTS13, recombinant-krhn (Adzynma) (PDF)  CP.PHAR.635  April 1, 2025
Adefovir (Hepsera) (PDF) CP.PHAR.142 December 1, 2025
Ado-Trastuzumab Emtansine (Kadcyla) (PDF)  CP.PHAR.229  July 1, 2025
Aducanumab-avwa (Aduhelm) (PDF)  CP.PHAR.468  July 1, 2025
Afamelanotide (Scenesse) (PDF)  CP.PHAR.444  April 1, 2025
Afamitresgene Autoleucel (Tecelra) (PDF)  CP.PHAR.678  Version effective until January 1, 2026
Afamitresgene Autoleucel (Tecelra) (PDF)  CP.PHAR.678  January 1, 2026
Afatinib (Gilotrif) (PDF)  CP.PHAR.298  July 1, 2025
Aflibercept (Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu) (PDF)   CP.PHAR.184     Version effective until February 1, 2026
Aflibercept (Eylea, Eylea HD, Opuviz, Yesafili, Ahzantive, Enzeevu, Pavblu) (PDF)   CP.PHAR.184     February 1, 2026
Agalsidase Beta (Fabrazyme) (PDF)  CP.PHAR.158  September 1, 2025
Age Limit Override (PDF) HIM.PA.177 January 1, 2026
Age Limit Override (Codeine, Tramadol, Hydrocodone) (PDF)   CP.PMN.138   October 1, 2025
Alectinib (Alecensa) (PDF)  CP.PHAR.369  July 1, 2025
Alemtuzumab (Lemtrada) (PDF)  CP.PHAR.243  July 1, 2025
Alendronate (Binosto, Fosamax plus D) (PDF)  CP.PMN.88  April 1, 2025
Alglucosidase Alfa (Lumizyme) (PDF)  CP.PHAR.160  April 1, 2025
Allogeneic Cultured Keratinocytes and Dermal Fibroblasts in Murine Collagen-dsat (StrataGraft) (PDF)   CP.PHAR.562  April 1, 2025
Allogenic Processed Thymus Tissue-agdc (Rethymic) (PDF)  CP.PHAR.563  April 1, 2025
Alpelisib (Piqray) (PDF)  CP.PHAR.430  December 1, 2025
Alpha1-Proteinase Inhibitors (Aralast NP, Glassia, Prolastin-C, Zemaira) (PDF)   CP.PHAR.94  April 1, 2025
Amantadine ER (Gocovri,Osmolex ER) (PDF)  CP.PMN.89  April 1, 2025
Ambrisentan (Letairis®) (PDF)  CP.PHAR.190  April 1, 2025
Amifampridine (Firdapse)(PDF)  CP.PHAR.411  April 1, 2025
Amikacin (Arikayce)(PDF)  CP.PHAR.401  October 1, 2025
Amisulpride (Barhemsys) (PDF)   CP.PMN.236  October 1, 2025
Amivantamab-vmjw (Rybrevant) (PDF)  CP.PHAR.544  October 1, 2025
Anifrolumab-fnia (Saphnelo) (PDF) CP.PHAR.551 December 1, 2025
Anti-Inhibitor Coagulant Complex, Human (Feiba) (PDF)  CP.PHAR.217  April 1, 2025
Antithrombin III (ATryn, Thrombate III) (PDF)  CP.PHAR.564  April 1, 2025
Antithymocyte Globulin (Atgam, Thymoglobulin) (PDF) CP.PHAR.506 December 1, 2025
Apalutamide (Erleada) (PDF)  CP.PCH.45  July 1, 2025
Apomorphine (Apokyn) (PDF)   CP.PHAR.488   October 1, 2025
Aprepitant (Emend®) (PDF)  CP.PMN.19  October 1, 2025
Aprocitentan (Tryvio) (PDF)  CP.PHAR.676  July 1, 2025
Arimoclomol (Miplyffa) (PDF) CP.PHAR.510 March 1, 2026
Aripiprazole Long-Acting Injections (Abilify Maintena, Abilify Asimtufii, Aristada, Aristada Initio) (PDF)   CP.PHAR.290  December 1, 2025
Aripiprazole ODT, oral film (Opipza, Mezofy) (PDF)   CP.PMN.300  August 1, 2025
Armodafinil (Nuvigil) (PDF)  CP.PMN.35  July 1, 2025
Asciminib (Scemblix) (PDF)  CP.PHAR.565  June 1, 2025
Asenapine (Saphris, Secuado) (PDF)  CP.PMN.15  October 1, 2025
Asfotase Alfa (Strensiq) (PDF) CP.PHAR.328 December 1, 2025
Aspirin-dipyridamole (Aggrenox) (PDF)  CP.PMN.20  April 1, 2025
AtezolizumaAtrasentan (Vanrafia)b (Tecentriq) (PDF)  CP.PHAR.235  June 1, 2025
Atidarsagene autotemcel (Lenmeldy) (PDF)   CP.PHAR.602   Version effective until January 1, 2026
Atidarsagene autotemcel (Lenmeldy) (PDF)   CP.PHAR.602   January 1, 2026
Atogepant (Qulipta) (PDF) CP.PHAR.566 December 1, 2025
Atrasentan (Vanrafia) (PDF) CP.PHAR.727 July 1, 2025
Avacincaptad pegol (Izervay) (PDF)  CP.PHAR.641  December 1, 2025
Avacopan (Tavneos) (PDF)  CP.PHAR.515  April 1, 2025
Avalglucosidase Alfa-ngpt (Nexviazyme) (PDF)  CP.PHAR.521  April 1, 2025
Avapritinib (Ayvakit) (PDF)  CP.PHAR.454  April 1, 2025
Avatrombopag (Doptelet) (PDF) CP.PHAR.130 Version effective until March 1, 2026
Avatrombopag (Doptelet) (PDF) CP.PHAR.130 March 1, 2026
Avelumab (Bavencio) (PDF)  CP.PHAR.333  April 1, 2025
Avutometinib, Defactinib (Avmapki Fakzynja Co-Pack) (PDF) CP.PHAR.731 October 1, 2025
Axatilimab-csfr (Niktimvo) (PDF)  CP.PHAR.691  Version effective until March 1, 2026
Axatilimab-csfr (Niktimvo) (PDF)  CP.PHAR.691  March 1, 2026
Axicabtagene Ciloleucel (Yescarta) (PDF)  CP.PHAR.362  Version effective until January 1, 2026
Axicabtagene Ciloleucel (Yescarta) (PDF)  CP.PHAR.362  January 1, 2026
Axitinib (Inlyta) (PDF)  CP.PHAR.100 April 1, 2025
Azacitidine (Onureg, Vidaza) (PDF) CP.PHAR.387 Version effective until March 1, 2026
Azacitidine (Onureg, Vidaza) (PDF) CP.PHAR.387 March 1, 2026
Azelaic Acid (Finacea) (PDF) HIM.PA.119 December 1, 2025
Aztreonam (Cayston) (PDF)  CP.PHAR.209  October 1, 2025
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) CP.PHAR.149 Version effective until March 1, 2026
Baclofen (Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax) (PDF) CP.PHAR.149 March 1, 2026
Baloxavir Marboxil (Xofluza) (PDF)  CP.PMN.185  December 1, 2025
Bedaquiline (Sirturo) (PDF)  CP.PMN.212  Version effective until February 1, 2026
Bedaquiline (Sirturo) (PDF)  CP.PMN.212  February 1, 2026
Belantamab Mafodotin-blmf (Blenrep) (PDF)  CP.PHAR.469  July 1, 2025
Belatacept (Nulojix) (PDF) CP.PHAR.201 December 1, 2025
Belimumab (Benlysta) (PDF)   CP.PHAR.88   October 1, 2025
Belinostat (Beleodaq) (PDF) CP.PHAR.311 December 1, 2025
Belumosudil (Rezurock) (PDF) CP.PHAR.552 Version effective until March 1, 2026
Belumosudil (Rezurock) (PDF) CP.PHAR.552 March 1, 2026
Belzutifan (Welireg) (PDF)  CP.PHAR.553  December 1, 2025
Bempedoic acid (Nexletol), bempedoic acid-ezetimibe (Nexlizet) (PDF)  CP.PMN.237  April 1, 2025
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) CP.PHAR.307 Version effective until March 1, 2026
Bendamustine (Belrapzo, Bendeka, Treanda, Vivimusta) (PDF) CP.PHAR.307 March 1, 2026
Benralizumab (Fasenra) (PDF) HIM.PA.SP70 Version effective until January 1, 2026
Benralizumab (Fasenra) (PDF) HIM.PA.SP70 January 1, 2026
Benznidazole (PDF)  CP.PMN.90  April 1, 2025
Berdazimer (Zelsuvmi) (PDF)  CP.PMN.293  July 1, 2025
Beremagene geperpavec-svdt (Vyjuvek) (PDF)  CP.PHAR.592  Version effective until February 1, 2026
Beremagene geperpavec-svdt (Vyjuvek) (PDF)  CP.PHAR.592  February 1, 2026
Berotralstat (Orladeyo) (PDF)  HIM.PA.169  October 1, 2025
Betaine (Cystadane) (PDF) CP.PHAR.143 December 1, 2025
Betamethasone Dipropionate Spray (Sernivo) (PDF) CP.PMN.182 December 1, 2025
Betibeglogene Autotemcel (Zynteglo) (PDF)   CP.PHAR.545  Version effective until January 1, 2026
Betibeglogene Autotemcel (Zynteglo) (PDF)   CP.PHAR.545  January 1, 2026
Bevacizumab (Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev) (PDF)    CP.PHAR.93  Version effective until March 1, 2026
Bevacizumab (Alymsys, Avastin, Avzivi, Jobevne, Mvasi, Vegzelma, Zirabev) (PDF)    CP.PHAR.93  March 1, 2026
Bexarotene (Targretin Capsules, Gel) (PDF)  CP.PHAR.75  July 1, 2025
Bezlotoxumab (Zinplava) (PDF)  CP.PHAR.300  April 1, 2025
Bimatoprost Implant (Durysta) (PDF)   CP.PHAR.486   October 1, 2025
Binimetinib (Mektovi) (PDF)  CP.PHAR.50  July 1, 2025
Biologic and Non-biologic DMARDs (PDF)    HIM.PA.SP60  Version effective until March 1, 2026
Biologic and Non-biologic DMARDs (PDF)    HIM.PA.SP60  March 1, 2026
Birch Triterpenes (Filsuvez) (PDF)  CP.PHAR.669  June 1, 2025
Blinatumomab (Blincyto) (PDF)   CP.PHAR.312  December 1, 2025
Bortezomib (Velcade) (PDF)  CP.PHAR.410  Version effective until February 1, 2026
Bortezomib (Velcade) (PDF)  CP.PHAR.410  February 1, 2026
Bosentan (Tracleer®) (PDF)  CP.PHAR.191  April 1, 2025
Bosutinib (Bosulif) (PDF)  CP.PHAR.105  July 1, 2025
Brand Name Override and Non-Formulary Medications (PDF)  HIM.PA.103 December 1, 2025
Brensocatib (Brinsupri) (PDF) CP.PMN.303 March 1, 2026
Brentuximab Vedotin (Adcetris) (PDF)    CP.PHAR.303   December 1, 2025
Brexanolone (Zulresso) (PDF)  CP.PHAR.417  July 1, 2025
Brexpiprazole (Rexulti) (PDF)  CP.PMN.68  October 1, 2025
Brexucabtagene Autoleucel (Tecartus) (PDF)  CP.PHAR.472  Version effective until January 1, 2026
Brexucabtagene Autoleucel (Tecartus) (PDF)  CP.PHAR.472  January 1, 2026
Brigatinib (Alunbrig) (PDF)  CP.PHAR.342  July 1, 2025
Brimonidine Tartrate (Mirvaso) (PDF)   CP.PMN.192   October 1, 2025
Brinzolamide/Brimonidine (Simbrinza) (PDF) HIM.PA.15 Version effective until March 1, 2026
Brivaracetam (Briviact) (PDF) CP.PMN.297 December 1, 2025
Brolucizumab-dbll (Beovu) (PDF)  CP.PHAR.445  June 1, 2025
Budesonide (Eohilia, Uceris) (PDF)  CP.PMN.294  July 1, 2025
Budesonide (Tarpeyo) (PDF)  CP.PHAR.572  April 1, 2025
Bupropion/Naltrexone (Contrave) (PDF)  CP.PCH.12  July 1, 2025
Burosumab-twza (Crysvita) (PDF)  CP.PHAR.11  December 1, 2025
Butorphanol Nasal Spray (PDF)  HIM.PA.46  July 1, 2025
C1 Esterase Inhibitors (Berinert, Cinryze, Haegarda, Ruconest) (PDF)   HIM.PA.170  October 1, 2025
Cabazitaxel (Jevtana) (PDF)  CP.PHAR.316  July 1, 2025
Cabotegravir (Apretude), Cabotegravir/Rilpivirine (Cabenuva) (PDF)   CP.PHAR.573  April 1, 2025
Cabozantinib (Cometriq®, Cabometyx®) (PDF)  CP.PHAR.111 April 1, 2025
Calcifediol (Rayaldee) (PDF)  CP.PMN.76  October 1, 2025
Calcipotriene/Betamethasone Dipropionate Foam (Enstilar) (PDF) CP.PMN.181 December 1, 2025
Canakinumab (Ilaris) (PDF)  CP.PHAR.246  Version effective until March 1, 2026
Canakinumab (Ilaris) (PDF)  CP.PHAR.246  March 1, 2026
Cannabidiol (Epidiolex) (PDF)  CP.PMN.164  October 1, 2025
Capecitabine (Xeloda) (PDF)  CP.PHAR.60  July 1, 2025
Capivasertib (Truqap) (PDF)  CP.PHAR.663  April 1, 2025
Caplacizumab-yhdp (Cablivi) (PDF)  CP.PHAR.416  July 1, 2025
Capmatinib (Tabrecta) (PDF)  CP.PHAR.494  October 1, 2025
CarbidopaLevodopa (Crexont, Rytary,Duopa, Dhivy), FoscarbidopaLevodopa (Vyalev) (PDF)   CP.PMN.238  October 1, 2025
Carfilzomib (Kyprolis) (PDF) CP.PHAR.309 Version effective until March 1, 2026
Carfilzomib (Kyprolis) (PDF) CP.PHAR.309 March 1, 2026
Carglumic acid (Carbaglu®) (PDF)  CP.PHAR.206  June 1, 2025
Cariprazine (Vraylar) (PDF)  CP.PMN.91  October 1, 2025
Casimersen (Amondys 45) (PDF)  CP.PHAR.470  April 1, 2025
Cemiplimab-rwlc (Libtayo) (PDF) CP.PHAR.397 Version effective until March 1, 2026
Cemiplimab-rwlc (Libtayo) (PDF) CP.PHAR.397 March 1, 2026
Cenegermin-bkbj (Oxervate)(PDF)  CP.PMN.186  April 1, 2025
Cenobamate (Xcopri) (PDF)  CP.PMN.231  April 1, 2025
Ceritinib (Zykadia) (PDF)  CP.PHAR.349  September 1, 2025
Cerliponase alfa (Brineura) (PDF)  CP.PHAR.338  October 1, 2025
Cetuximab (Erbitux) (PDF) CP.PHAR.317 Version effective until March 1, 2026
Cetuximab (Erbitux) (PDF) CP.PHAR.317 March 1, 2026
Chenodiol (Chenodal) (PDF)   CP.PMN.239   December 1, 2025
Chlorambucil (Leukeran) (PDF) CP.PHAR.554 Version effective until March 1, 2026
Chlorambucil (Leukeran) (PDF) CP.PHAR.554 March 1, 2026
Chloramphenicol Sodium Succinate (PDF)  CP.PHAR.388  October 1, 2025
Cholic Acid (Cholbam) (PDF) CP.PHAR.390 December 1, 2025
Ciclopirox (Penlac) (PDF)  CP.PMN.24  April 1, 2025
Ciltacabtagene Autoleucel (Carvykti) (PDF)  CP.PHAR.533  Version effective until January 1, 2026
Ciltacabtagene Autoleucel (Carvykti) (PDF)  CP.PHAR.533  January 1, 2026
Cinacalcet (Sensipar) (PDF)  CP.PHAR.61  December 1, 2025
Cipaglucosidase Alfa-atga + Miglustat (Pombiliti + Opfolda) (PDF)  CP.PHAR.567  April 1, 2025
Ciprofloxacin/Fluocinolone (Otovel) (PDF) CP.PMN.249 Version effective until March 1, 2026
Ciprofloxacin/Fluocinolone (Otovel) (PDF) CP.PMN.249 March 1, 2026
Ciprofloxacin-Dexamethasone (Ciprodex) (PDF) CP.PMN.248 Version effective until March 1, 2026
Cladribine (Mavenclad) (PDF)   CP.PHAR.422   October 1, 2025
Clascoterone (Winlevi) (PDF)  CP.PMN.257  April 1, 2025
Clesrovimab-cfor (Enflonsia) (PDF) CP.PHAR.741 October 1, 2025
Clobazam (Onfi) (PDF) CP.PMN.54 December 1, 2025
CNS Stimulants (PDF)  CP.PMN.92 June 1, 2025
Cobimetinib (Cotellic) (PDF)  CP.PHAR.380  July 1, 2025
Colchicine (Colcrys, Lodoco) (PDF)  CP.PMN.123  April 1, 2025
Colesevelam (Welchol) (PDF) CP.PMN.250 December 1, 2025
Collagenase Clostridium Histolyticum (Xiaflex) (PDF)  CP.PHAR.82  October 1, 2025
Colonoscopy Preparation Products (PDF) CP.PCH.43 December 1, 2025
Compounded Medications (PDF)    CP.PMN.280    December 1, 2025
Concizumab (Alhemo) (PDF)  CP.PHAR.625  Version effective until January 1, 2026
Concizumab (Alhemo) (PDF)  CP.PHAR.625  January 1, 2026
Conjugated Estrogens/Bazedoxifene (Duavee) (PDF)  CP.PMN.258  December 1, 2025
Continuous Glucose Monitors (PDF)  Continuous Glucose Monitors (PDF)  AR.QC.PMN.214 Version effective until March 1, 2026
Continuous Glucose Monitors (PDF)  AR.QC.PMN.214  March 1, 2026
Copanlisib (Aliqopa) (PDF) CP.PHAR.357 Version effective until March 1, 2026
Corticosteroids for Ophthalmic Injection (Dextenza, Iluvien, Ozurdex, Retisert, Xipere, Yutiq) (PDF)   CP.PHAR.385  October 1, 2025
Cosibelimab-Ipdl (Unloxcyt) (PDF)  CP.PHAR.711  August 1, 2025
Cosyntropin (Cortrosyn) (PDF)  CP.PHAR.203  June 1, 2025
Crinecerfont (Crenessity) (PDF) CP.PHAR.692 December 1, 2025
Crisaborole (Eucrisa) (PDF)  CP.PMN.110  December 1, 2025
Crizanlizumab-tmca (Adakveo) (PDF)   CP.PHAR.449   December 1, 2025
Crizotinib (Xalkori) (PDF)  CP.PHAR.90  July 1, 2025
Crovalimab (PiaSky) (PDF)   CP.PHAR.664   October 1, 2025
Cyclosporine ophthalmic emulsion (Cequa, Klarity-C, Restasis, Verkazia, Vevye) (PDF)   CP.PMN.48   October 1, 2025
Cysteamine Ophthalmic (Cystaran, Cystadrops) (PDF)  CP.PMN.130  July 1, 2025
Cysteamine oral (Cystagon, Procysbi) (PDF)   CP.PHAR.155   October 1, 2025
Cytomegalovirus Immune Globulin (Cytogam) (PDF)  CP.PHAR.277  October 1, 2025
Dabrafenib (Tafinlar) (PDF)  CP.PHAR.239  July 1, 2025
Dacomitinib (Vizimpro) (PDF) CP.PHAR.399 Version effective until March 1, 2026
Dacomitinib (Vizimpro) (PDF) CP.PHAR.399 March 1, 2026
Dalfampridine (Ampyra) (PDF)  CP.PHAR.248  July 1, 2025
Dalteparin (Fragmin) (PDF)  CP.PHAR.225  April 1, 2025
Danicopan (ALXN2040) (PDF)  CP.PHAR.665  December 1, 2025
Daprodustat (Jesduvroq) (PDF)  CP.PHAR.628  July 1, 2025
Dapsone (Aczone Gel) (PDF) CP.PCH.32 December 1, 2025
Daptomycin (Cubicin, Cubicin RF, Dapzura RT) (PDF)  CP.PHAR.351  October 1, 2025
Daratumumab (Darzalex), Daratumumab/Hyaluronidase-fihj (Darzalex Faspro) (PDF) CP.PHAR.310  January 1, 2026
Darbepoetin alfa (Aranesp) (PDF)  CP.PHAR.236  September 1, 2025
Darolutamide (Nubeqa) (PDF)  CP.PHAR.435  December 1, 2025
Dasabuvir-Ombitasvir-Paritaprevir-Ritonavir (Viekira Pak) (PDF) HIM.PA.SP61 January 1, 2025
Dasatinib (Sprycel, Phyrago) (PDF)   CP.PHAR.72   October 1, 2025
Datopotamab Deruxtecan-dlnk (Datroway) (PDF)   CP.PHAR.715   November 1, 2025
Daunorubicin/Cytarabine (Vyxeos) (PDF) CP.PHAR.352 Version effective until March 1, 2026
Daunorubicin/Cytarabine (Vyxeos) (PDF) CP.PHAR.352 March 1, 2026
DaxibotulinumtoxinA-lanm (Daxxify) (PDF) CP.PHAR.651 December 1, 2025
Decitabine-Cedazuridine (Inqovi) (PDF)   CP.PHAR.479   October 1, 2025
Deferasirox (Exjade Jadenu) (PDF)  CP.PHAR.145  December 1, 2025
Deferiprone (Ferriprox) (PDF)  CP.PHAR.147  December 1, 2025
Deferoxamine (Desferal) (PDF)  CP.PHAR.146  December 1, 2025
Deflazacort (Emflaza) (PDF)  CP.PHAR.331  April 1, 2025
Degarelix Acetate (Firmagon) (PDF) CP.PHAR.170 December 1, 2025
Delafloxacin (Baxdela) (PDF)  CP.PMN.115  October 1, 2025
Delandistrogene moxeparvovec-rokl (Elevidys) (PDF)  CP.PCH.56 January 1, 2026
Delgocitinib (Anzupgo) (PDF) CP.PHAR.744 March 1, 2026
Denileukin Diftitox-cxdl (Lymphir) (PDF)  CP.PHAR.693  December 1, 2025
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF)   CP.PHAR.58  Version effective until March 1, 2026
Denosumab (Prolia, Xgeva), Denosumab-bbdz (Jubbonti, Wyost) (PDF)   CP.PHAR.58  March 1, 2026
Desmopressin Acetate (DDAVP, Stimate, Noctiva) (PDF)  CP.PHAR.214  June 1, 2025
Deutetrabenazine (Austedo, Austedo XR) (PDF)  CP.PCH.42  July 1, 2025
Dexrazoxane (Totect) (PDF)  CP.PHAR.418  September 1, 2025
Dextromethorphan-bupropion (Auvelity) (PDF) CP.PMN.284 December 1, 2025
Dextromethorphan-Quinidine (Nuedexta) (PDF) CP.PMN.93 April 1, 2025
Diazepam (Libervant, Valtoco) (PDF) CP.PMN.216 December 1, 2025
Diazoxide Choline (Vykat XR) (PDF) CP.PHAR.701 December 1, 2025
Dichlorphenamide (Keveyis) (PDF)  CP.PMN.261  April 1, 2025
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) CP.PCH.28 Version effective until March 1, 2026
Diclofenac (Cambia, Flector, Licart, Pennsaid, Solaraze, Zipsor, Zorvolex) (PDF) CP.PCH.28 March 1, 2026
Dimethyl Fumarate (Tecfidera), Diroximel Fumarate (Vumerity), Monomethyl Fumarate (Bafiertam) (PDF)   CP.PHAR.249   October 1, 2025
Dipeptidyl Peptidase-4 Inhibitors (PDF)   HIM.PA.58   May 1, 2025
Dolasetron (Anzemet) (PDF)  CP.PMN.141  October 1, 2025
Donanemab-azbt (Kisunla) (PDF) CP.PHAR.594 Version effective until March 1, 2026
Donanemab-azbt (Kisunla) (PDF) CP.PHAR.594 March 1, 2026
Donidalorsen (Dawnzera) CP.PHAR.717 January 1, 2026
Donidalorsen (Dawnzera) CP.PHAR.717 Version effective until January 1, 2026
Dordaviprone (Modeyso) (PDF) CP.PHAR.745 March 1, 2026
Dornase alfa (Pulmozyme) (PDF)  CP.PHAR.212  October 1, 2025
Dostarlimab-gxly (Jemperli) (PDF)  CP.PHAR.540  December 1, 2025
Doxepin (Silenor, Prudoxin, Zonalon) (PDF) HIM.PA.147 Version effective until March 1, 2026
Doxepin (Silenor, Prudoxin, Zonalon) (PDF) HIM.PA.147 March 1, 2026
Doxycycline Hyclate (Acticlate, Doryx), Doxycycline (Oracea) (PDF)   CP.PMN.79   October 1, 2025
Dupilumab (Dupixent) (PDF)    HIM.PA.SP69   December 1, 2025
Durvalumab (Imfinzi) (PDF)  CP.PHAR.339  January 1, 2026
Dutasteride (Avodart), Dutasteride/Tamsulosin (Jalyn) (PDF)  CP.PMN.128  July 1, 2025
Duvelisib (Copiktra) (PDF) CP.PHAR.400 Version effective until March 1, 2026
Duvelisib (Copiktra) (PDF) CP.PHAR.400 March 1, 2026
Ecallantide (Kalbitor) (PDF)  CP.PHAR.177  October 1, 2025
Eculizumab (Soliris) (PDF)   CP.PHAR.97   December 1, 2025
Edaravone (Radicava, Radicava ORS) (PDF)  CP.PHAR.343  September 1, 2025
Efgartigimod Alfa-fcab, Efgartigimod/-Hyaluronidase-qvfc (Vyvgart, Vyvgart Hytrulo) (PDF)   CP.PHAR.555  July 1, 2025
Efinaconazole (Jublia) (PDF)  CP.PMN.25  April 1, 2025
Eflornithine (Iwilfin) (PDF)  CP.PHAR.670  April 1, 2025
Elacestrant (Orserdu) (PDF)  CP.PHAR.623  September 1, 2025
Eladocagene Exuparvovec-tneq (Kebilidi) (PDF)  CP.PHAR.595  Version effective until January 1, 2026
Eladocagene Exuparvovec-tneq (Kebilidi) (PDF)  CP.PHAR.595  January 1, 2026
Elafibranor (Iqirvo) (PDF)  CP.PHAR.688  October 1, 2025
Elagolix (Orilissa), elagolix-estradiol-norethindrone (Oriahnn) (PDF) CP.PHAR.136 December 1, 2025
Elamipretide (Forzinity) (PDF) CP.PHAR.680 January 1, 2026
Elapegademase-lvlr (Revcovi) (PDF)   CP.PHAR.419  July 1, 2025
Elbasvir/Grazoprevir (Zepatier) (PDF)  HIM.PA.SP62  December 1, 2025
Elexacaftor-ivacaftor-tezacaftor (Trikafta) (PDF)   CP.PHAR.440   December 1, 2025
Eliglustat (Cerdelga) (PDF)  CP.PHAR.153  July 1, 2025
Elivaldogene Autotemcel (Skysona) (PDF) CP.PHAR.556 Version effective until March 1, 2026
Elivaldogene Autotemcel (Skysona) (PDF) CP.PHAR.556 March 1, 2026
Elosulfase Alfa (Vimizim) (PDF)  CP.PHAR.162  July 1, 2025
Elotuzumab (Empliciti) (PDF) CP.PHAR.308 December 1, 2025
Elranatamab-bcmm (Elrexfio) (PDF) CP.PHAR.652 Version effective until March 1, 2026
Elranatamab-bcmm (Elrexfio) (PDF) CP.PHAR.652 March 1, 2026
Eltrombopag (Promacta®) (PDF)  CP.PHAR.180  Version effective until January 1, 2026
Eltrombopag (Promacta®) (PDF)  CP.PHAR.180  January 1, 2026
Eluxadoline (Viberzi) (PDF) CP.PMN.170 December 1, 2025
Emapalumab-lzsg (Gamifant) (PDF)   CP.PHAR.402   October 1, 2025
Emicizumab-kxwh (Hemlibra) (PDF)  CP.PHAR.370  April 1, 2025
Emtricitabine-tenofovir alafenamide (Descovy) (PDF)  CP.PMN.235  July 1, 2025
Ensartinib (Ensacove) (PDF) CP.PHAR.712 April 1, 2025
Enasidenib (Idhifa) (PDF) CP.PHAR.363 December 1, 2025
Encorafenib (Braftovi) (PDF)  CP.PHAR.127  July 1, 2025
Enfortumab Vedotin-ejfv (Padcev) (PDF)  CP.PHAR.455  April 1, 2025
Enfuvirtide (Fuzeon) (PDF)  CP.PHAR.41  October 1, 2025
Enoxaparin (Lovenox) (PDF)  CP.PHAR.224  April 1, 2025
Entecavir (Baraclude) (PDF)   HIM.PA.08   November 1, 2025
Entrectinib (Rozlytrek) (PDF) CP.PHAR.441 Version effective until March 1, 2026
Entrectinib (Rozlytrek) (PDF) CP.PHAR.441 March 1, 2026
Enzalutamide (Xtandi) (PDF)  CP.PHAR.106 April 1, 2025
Epcoritamab-bysp (Epkinly) (PDF)  CP.PHAR.634  October 1, 2025
Epinephrine (Epipen, Epipen Jr, Neffy, Auvi-Q) (PDF)  CP.PCH.55  December 1, 2025
Eplontersen (Wainua)  CP.PHAR.633  July 1, 2025
Epoetin Alfa (Epogen, Procrit), Epoetin Alfa-epbx (Retacrit) (PDF)    CP.PHAR.237   August 1, 2025
Epoprostenol (Flolan, Veletri) (PDF)  CP.PHAR.192  April 1, 2025
Eptinezumab-jjmr (Vyepti) (PDF) HIM.PA.SP64 December 1, 2025
Erdafitinib (Balversa) (PDF)  CP.PHAR.423  October 1, 2025
Erenumab-aaoe (Aimovig) (PDF) HIM.PA.SP65 December 1, 2025
Eribulin Mesylate (Halaven) (PDF) CP.PHAR.318 Version effective until March 1, 2026
Eribulin Mesylate (Halaven) (PDF) CP.PHAR.318 March 1, 2026
Erlotinib (Tarceva) (PDF)  CP.PHAR.74  July 1, 2025
Erwinia Asparaginase (Erwinaze, Rylaze) (PDF)  CP.PHAR.301  April 1, 2025
Esketamine (Spravato) (PDF)   CP.PMN.199   July 1, 2025
Estradiol Vaginal Ring (Femring) (PDF)  CP.PMN.263  October 1, 2025
Etelcalcetide (Parsabiv) (PDF)  CP.PHAR.379  October 1, 2025
Eteplirsen (Exondys 51) (PDF)  CP.PHAR.288  April 1, 2025
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF)  CP.PHAR.580  Version effective until January 1, 2026
Etranacogene Dezaparvovec-drlb (Hemgenix) (PDF)  CP.PHAR.580  January 1, 2026
Everolimus (Afinitor, Afinitor Disperz, Zortress)(PDF)  CP.PHAR.63  April 1, 2025
Evinacumab-dgnb (Evkeeza) (PDF)  HIM.PA.166  Version effective until February 1, 2026
Evinacumab-dgnb (Evkeeza) (PDF)  HIM.PA.166  February 1, 2026
Evolocumab (Repatha) (PDF)  HIM.PA.156  December 1, 2025
Exagamglogene autotemcel (Casgevy) (PDF)  CP.PHAR.603  Version effective until January 1, 2026
Exagamglogene autotemcel (Casgevy) (PDF)  CP.PHAR.603  January 1, 2026
Factor IX (Human, Recombinant) (PDF)  CP.PHAR.218  April 1, 2025
Factor IX Complex, Human (Profilnine) (PDF)  CP.PHAR.219  April 1, 2025
Factor VIIa, Recombinant (NovoSeven RT, SevenFact) (PDF)   CP.PHAR.220  June 1, 2025
Factor VIII (Human, Recombinant) (PDF)    CP.PHAR.215    August 1, 2025
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF)   CP.PHAR.216  Version effective until February 1, 2026
Factor VIII/von Willebrand Factor Complex (Human – Alphanate, Humate-P, Wilate); von Willebrand Factor (Recombinant – Vonvendi) (PDF)   CP.PHAR.216  February 1, 2026
Factor XIII A-Subunit, Recombinant (Tretten) (PDF)  CP.PHAR.222  April 1, 2025
Factor XIII, Human (Corifact) (PDF)  CP.PHAR.221  April 1, 2025
Famotidine-Ibuprofen (Duexis) (PDF)    CP.PMN.120    October 1, 2025
Fam-Trastuzumab Deruxtecan-nxki (Enhertu) (PDF)  CP.PHAR.456  April 1, 2025
Faricimab-svoa (Vabysmo) (PDF)  CP.PHAR.581  April 1, 2025
Febuxostat (Uloric) (PDF)  CP.PMN.57  April 1, 2025
Fecal microbiota spores, live-brpk (Vowst) (PDF)  CP.PHAR.632  October 1, 2025
Fecal microbiota, live-jslm (Rebyota) (PDF)  CP.PHAR.613  April 1, 2025
Fedratinib (Inrebic) (PDF) CP.PHAR.442 Version effective until March 1, 2026
Fedratinib (Inrebic) (PDF) CP.PHAR.442 March 1, 2026
Fenfluramine (Fintepla) (PDF)  CP.PMN.246  October 1, 2025
Fentanyl IR (Abstral, Actiq, Fentora, Lazanda, Subsys) (PDF)  CP.PMN.127  July 1, 2025
Ferric Carboxymaltose (Injectafer) (PDF)  CP.PHAR.234  Version effective until January 1, 2026
Ferric Carboxymaltose (Injectafer) (PDF)  CP.PHAR.234  January 1, 2026
Ferric Derisomaltose (Monoferric) (PDF)   CP.PHAR.480  Version effective until January 1, 2026
Ferric Derisomaltose (Monoferric) (PDF)   CP.PHAR.480  January 1, 2026
Ferric Maltol (Accrufer) (PDF) CP.PMN.213 December 1, 2025
Ferric Pyrophosphate (Triferic, Triferic Avnu ) (PDF)  CP.PHAR.624  July 1, 2025
Ferumoxytol (Feraheme) (PDF)  CP.PHAR.165  Version effective until January 1, 2026
Ferumoxytol (Feraheme) (PDF)  CP.PHAR.165  January 1, 2026
Fezolinetant (Veozah) (PDF)  CP.PMN.289  October 1, 2025
Fibrinogen Concentrate [Human] (Fibryga, RiaSTAP) (PDF)  CP.PHAR.526  July 1, 2025
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) CP.PHAR.643 Version effective until January 1, 2026
Fidanacogene Elaparvovec-dzkt (Beqvez) (PDF) CP.PHAR.643 January 1, 2026
Filgrastim (Neupogen, Zarxio, Granix, Nivestym, Releuko, Nypozi) (PDF)    CP.PHAR.297   October 1, 2025
Finerenone (Kerendia) (PDF) CP.PMN.266 Version effective until March 1, 2026
Finerenone (Kerendia) (PDF) CP.PMN.266 March 1, 2026
Fingolimod (Gilenya) (PDF)  CP.PCH.38  July 1, 2025
Fingolimod (Gilenya, Tascenso ODT) (PDF)  CP.PHAR.251  October 1, 2025
Fitusiran (Qfitlia) PDF  CP.PHAR.706  November 1, 2025
Flibanserin (Addyi) (PDF) CP.PHAR.446 January 1, 2025
Fluorouracil Cream (Tolak) (PDF) CP.PMN.165 December 1, 2025
Fluticasone Propionate (Xhance) (PDF)  CP.PMN.95  December 1, 2025
Fondaparinux (Arixtra) (PDF) CP.PHAR.226 April 1, 2025
Fosdenopterin (Nulibry) (PDF)   CP.PHAR.471   November 1, 2025
Fostamatinib (Tavalisse) (PDF)  CP.PHAR.24  Version effective until January 1, 2026
Fostamatinib (Tavalisse) (PDF)  CP.PHAR.24  January 1, 2026
Fostemsavir (Rukobia) (PDF)   CP.PHAR.516   October 1, 2025
Fremanezumab-vfrm (Ajovy)(PDF) HIM.PA.SP66 December 1, 2025
Fruquintinib (Fruzaqla) (PDF)  CP.PHAR.666  April 1, 2025
Fulvestrant (Faslodex Injection) (PDF)   CP.PHAR.424  December 1, 2025
Furosemide (Furoscix) (PDF)  CP.PHAR.608  April 1, 2025
Futibatinib (Lytgobi) (PDF)  CP.PHAR.604  April 1, 2025
Gabapentin ER (Gralise, Horizant) (PDF)  CP.PMN.240  December 1, 2025
Galcanezumab-gnlm (Emgality) (PDF)  HIM.PA.SP67  December 1, 2025
Galsulfase (Naglazyme) (PDF)  CP.PHAR.161  July 1, 2025
Ganaxolone (Ztalmy) (PDF)  CP.PMN.278  July 1, 2025
Garadacimab (Andembry) (PDF) CP.PHAR.673 Version effective until March 1, 2026
Garadacimab (Andembry) (PDF) CP.PHAR.673 March 1, 2026
Gefitinib (Iressa) (PDF)  CP.PHAR.68  July 1, 2025
Gemcitabine Intravesical System (Inlexzo) (PDF) CP.PHAR.753 December 1, 2025
Gemtuzumab Ozogamicin (Mylotarg) (PDF) CP.PHAR.358 December 1, 2025
Gilteritinib (Xospata) (PDF)  CP.PHAR.412  April 1, 2025
Givinostat (Duvyzat) (PDF)  CP.PHAR.644  October 1, 2025
Givosiran (Givlaari) (PDF)  CP.PHAR.457  April 1, 2025
Glasdegib (Daurismo)(PDF)  CP.PHAR.413  April 1, 2025
Glatiramer (Copaxone, Glatopa) (PDF)  CP.PHAR.252  July 1, 2025
Glaucoma Agents (Omlonti, Rhopressa, Rocklatan, Vyzulta) (PDF)  CP.PMN.286  December 1, 2025
Glecaprevir/Pibrentasvir (Mavyret)(PDF)  HIM.PA.SP36  December 1, 2025
Glofitamab-gxbm (Columvi) (PDF)  CP.PHAR.636  October 1, 2025
GLP-1 Receptor Agonists (PDF) AR.QC.PA.53 January 1, 2026
Glycerol Phenylbutyrate (Ravicti) (PDF)  CP.PHAR.207  April 1, 2025
Golodirsen (Vyondys 53) (PDF)  CP.PHAR.453  April 1, 2025
Goserelin Acetate (Zoladex) (PDF)  CP.PHAR.171  Version effective until March 1, 2026
Goserelin Acetate (Zoladex) (PDF)  CP.PHAR.171  March 1, 2026
Granisetron (Sancuso, Sustol) (PDF)  CP.PMN.74  October 1, 2025
Halcinonide (Halog) (PDF) HIM.PA.20 December 1, 2025
Halobetasol Propionate Lotion (Bryhali, Lexette, Ultravate) (PDF) CP.PMN.180 December 1, 2025
Halobetasol Propionate/Tazarotene (Duobrii) (PDF)  CP.PMN.208  ctober 1, 2025
Hemin (Panhematin) (PDF)  CP.PHAR.181  April 1, 2025
Histrelin Acetate (Vantas, Supprelin LA) (PDF)  CP.PHAR.172  July 1, 2025
House dust mite allergen extract (Odactra®) (PDF)  CP.PMN.111  October 1, 2025
Human Growth Hormone (Somapacitan, Somatropin) (PDF)  HIM.PA.161  Version effective until February 1, 2026
Human Growth Hormone (Somapacitan, Somatropin) (PDF)  HIM.PA.161  February 1, 2026
Hyaluronate derivatives (PDF) CP.PHAR.05 December 1, 2025
Hydroxyprogesterone Caproate (Makena) (PDF)  CP.PHAR.14  July 1, 2025
Hydroxyurea (Siklos, Xromi) (PDF)   CP.PMN.193   November 1, 2025
Ibalizumab-uiyk (Trogarzo) (PDF)   CP.PHAR.378   October 1, 2025
Ibandronate Injection (Boniva) (PDF)   CP.PHAR.189   October 1, 2025
Ibrutinib (Imbruvica) (PDF)  CP.PHAR.126  June 1, 2025
Icatibant (Firazyr®) (PDF)  CP.PHAR.178  October 1, 2025
Icosapent ethyl (Vascepa) (PDF)  CP.PMN.187  April 1, 2025
Idecabtagene Vicleucel (Abecma) (PDF)  CP.PHAR.481  Version effective until January 1, 2026
Idecabtagene Vicleucel (Abecma) (PDF)  CP.PHAR.481  January 1, 2026
Idelalisib (Zydelig) (PDF) CP.PHAR.133 December 1, 2025
Idursulfase (Elaprase) (PDF)  CP.PHAR.156  July 1, 2025
Iloperidone (Fanapt) (PDF)  CP.PMN.32  October 1, 2025
Iloprost (Ventavis®) (PDF)  CP.PHAR.193  April 1, 2025
Imatinib (Gleevec, Imkeldi) (PDF)  CP.PHAR.65  July 1, 2025
Imetelstat (Rytelo) (PDF)  CP.PHAR.690  October 1, 2025
Imiglucerase (Cerezyme) (PDF)  CP.PHAR.154  July 1, 2025
Imlunestrant (Inluriyo) (PDF) CP.PHAR.754 December 1, 2025
Immune Globulins (PDF) HIM.PA.178 January 1, 2026
Immune Globulins (PDF)  CP.PHAR.103  Version effective until February 1, 2026
Immune Globulins (PDF)  CP.PHAR.103  February 1, 2026
Immune Globulins for PANS/PANDAS (PDF) AR.CP.PHAR.103 February 1, 2025
Inavolisib (Itovebi) (PDF) CP.PHAR.702 Version effective until March 1, 2026
Inavolisib (Itovebi) (PDF) CP.PHAR.702 March 1, 2026
Inclisiran (Leqvio) (PDF)   CP.PHAR.568   October 1, 2025
IncobotulinumtoxinA (Xeomin) (PDF)   CP.PHAR.231   October 1, 2025
Inebilizumab-cdon (Uplizna) (PDF)  CP.PHAR.458 December 1, 2025
Infertility and Fertility Preservation (PDF) CP.PHAR.131 Version effective until March 1, 2026
Infertility and Fertility Preservation (PDF) CP.PHAR.131 March 1, 2026
Inhaled asthma and COPD agents (PDF)   HIM.PA.153   Version effective until January 1, 2026
Inhaled asthma and COPD agents (PDF)   HIM.PA.153   January 1, 2026
Inotersen (Tegsedi) (PDF)  CP.PHAR.405  July 1, 2025
Inotuzumab Ozogamicin (Besponsa) (PDF) CP.PHAR.359 Version effective until March 1, 2026
Inotuzumab Ozogamicin (Besponsa) (PDF) CP.PHAR.359 March 1, 2026
Insulin Delivery Systems (V-Go, Omnipod, InPen) (PDF)      CP.PHAR.534    November 1, 2025
Insulin Detemir (Levemir) (PDF)  HIM.PA.171  Version effective until January 1, 2026
Insulin Detemir (Levemir) (PDF)  HIM.PA.171  January 1, 2026
Insulin Glargine (Basaglar, Rezvoglar, Toujeo, unbranded Semglee) (PDF)   HIM.PA.09   January 1, 2026
Interferon Beta-1a (Avonex, Rebif) (PDF)  CP.PHAR.255  July 1, 2025
Interferon beta-1b (Betaseron, Extavia) (PDF)   CP.PCH.46   October 1, 2025
Interferon Gamma- 1b (Actimmune) (PDF)  CP.PHAR.52  April 1, 2025
Iobenguane I-131 (Azedra) (PDF)  CP.PHAR.459  April 1, 2025
Ipilimumab (Yervoy) (PDF)   CP.PHAR.319 October 1, 2025
Iptacopan (Fabhalta) (PDF)   CP.PHAR.656   December 1, 2025
Irinotecan Liposome (Onivyde) (PDF) CP.PHAR.304 Version effective until March 1, 2026
Irinotecan Liposome (Onivyde) (PDF) CP.PHAR.304 March 1, 2026
Isatuximab-irfc (Sarclisa) (PDF)  CP.PHAR.482  July 1, 2025
Isavuconazonium (Cresemba) (PDF)  CP.PMN.154  Version effective until March 1, 2026
Isavuconazonium (Cresemba) (PDF)  CP.PMN.154  March 1, 2026
Isotretinoin (Claravis Absorica Absorica LD Myorisan Zenatane Amnesteem) (PDF) CP.PMN.143 December 1, 2025
Istradefylline (Nourianz) (PDF)  CP.PMN.217  April 1, 2025
Itraconazole (Sporanox, Onmel) (PDF)  CP.PMN.124  July 1, 2025
Ivabradine (Corlanor) (PDF)  CP.PMN.70  June 1, 2025
Ivacaftor (Kalydeco) (PDF)   CP.PHAR.210   December 1, 2025
Ivermectin (Stromectol, Sklice) (PDF)  CP.PMN.269  October 1, 2025
Ivosidenib (Tibsovo) (PDF) CP.PHAR.137 Version effective until March 1, 2026
Ivosidenib (Tibsovo) (PDF) CP.PHAR.137 March 1, 2026
Ixazomib (Ninlaro) (PDF)  CP.PHAR.302  December 1, 2025
Ketamine (Ketalar) (PDF)  CP.PMN.296  October 1, 2025
Ketorolac nasal spray (Sprix) (PDF) CP.PMN.282 December 1, 2025
Lanadelumab-fylo (Takhzyro) (PDF)  HIM.PA.172  October 1, 2025
Lanreotide (Somatuline Depot and Unbranded) (PDF) CP.PHAR.391 December 1, 2025
Lapatinib (Tykerb®) (PDF) CP.PHAR.79 Version effective until March 1, 2026
Lapatinib (Tykerb®) (PDF) CP.PHAR.79 March 1, 2026
Laronidase (Aldurazyme) (PDF)  CP.PHAR.152  July 1, 2025
Larotrectinib (Vitrakvi)(PDF)   CP.PHAR.414   October 1, 2025
Lasmiditan (Reyvow) (PDF)  CP.PMN.218  December 1, 2025
Lazertinib (Lazcluze) (PDF) CP.PHAR.695 December 1, 2025
Lebrikizumab (Ebglyss) (PDF)  CP.PHAR.704 Version effective until March 1, 2026
Lebrikizumab (Ebglyss) (PDF)  CP.PCH.58 March 1, 2026
Lecanemab-irmb (Leqembi) (PDF)  CP.PHAR.596  Version effective until March 1, 2026
Lecanemab-irmb (Leqembi) (PDF)  CP.PHAR.596  March 1, 2026
Ledipasvir-Sofosbuvir (Harvoni) (PDF)  HIM.PA.SP3  December 1, 2025
Lefamulin (Xenleta) (PDF)  CP.PMN.219  October 1, 2025
Lenacapavir (Sunlenca) (PDF)    CP.PHAR.622    December 1, 2025
Lenalidomide (Revlimid) (PDF)  CP.PHAR.71  September 1, 2025
Leniolisib (Joenja) (PDF) CP.PHAR.597 December 1, 2025
Lenvatinib (Lenvima) (PDF)  CP.PHAR.138  Version effective until March  1, 2026
Lenvatinib (Lenvima) (PDF)  CP.PHAR.138  March  1, 2026
Letermovir (Prevymis) (PDF)   CP.PHAR.367 Version effective until February 1, 2026
Letermovir (Prevymis) (PDF)   CP.PHAR.367 February 1, 2026
Leucovorin Injection (PDF) CP.PHAR.393 Version effective until March 1, 2026
Leucovorin Injection (PDF) CP.PHAR.393 March 1, 2026
Leuprolide Acetate (Eligard, Fensolvi, Lupaneta Pack, Lupron Depot, Lupron Depot-Ped), Leuprolide mesylate (Camcevi) (PDF) CP.PHAR.173 May 1, 2024
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)   CP.PCH.53  Version effective until March 1, 2026
Leuprolide Acetate (Lupron, Eligard, Lupaneta Pack, Fensolvi, Camcevi) (PDF)   CP.PCH.53  March 1, 2026
Levacetylleucine (Aqneursa) (PDF) CP.PHAR.682 Version effective until March 1, 2026
Levacetylleucine (Aqneursa) (PDF) CP.PHAR.682 March 1, 2026
Levodopa Inhalation Powder (Inbrija) (PDF) CP.PMN.267 Version effective until March 1, 2026
Levodopa Inhalation Powder (Inbrija) (PDF) CP.PMN.267 March 1, 2026
Levoketoconazole (Recorlev) (PDF)   CP.PMN.275   October 1, 2025
Levoleucovorin (Fusilev, Khapzory) (PDF) CP.PHAR.151 December 1, 2025
Levomilnacipran (Fetzima) (PDF)  HIM.PA.125  December 1, 2025
L-glutamine (Endari) (PDF) CP.PMN.116 December 1, 2025
Lidocaine Transdermal (Lidoderm, ZTlido) (PDF)  CP.PMN.08  December 1, 2025
Lifileucel (Amtagvi) (PDF) CP.PHAR.598 Version effective until January 1, 2026
Lifileucel (Amtagvi) (PDF) CP.PHAR.598 January 1, 2026
Lifitegrast (Xiidra®) (PDF)  CP.PMN.73  April 1, 2025
Linezolid (Zyvox) (PDF)  CP.PMN.27  October 1, 2025
Linvoseltamab-gcpt (Lynozyfic) (PDF)  CP.PHAR.743  November 1, 2025
Lisocabtagene Maraleucel (Breyanzi) (PDF)  CP.PHAR.483  Version effective until February 1, 2026
Lisocabtagene Maraleucel (Breyanzi) (PDF)  CP.PHAR.483  February 1, 2026
Lofexidine (Lucemyra) (PDF)   CP.PMN.152   October 1, 2025
Lomustine (Gleostine) (PDF) CP.PHAR.507 December 1, 2025
Lonafarnib (Zokinvy) (PDF)  CP.PHAR.499  April 1, 2025
Loncastuximab Tesirine-lpyl (Zynlonta) (PDF)  CP.PHAR.539  October 1, 2025
Lorlatinib (Lorbrena)(PDF)  CP.PHAR.406  September 1, 2025
Loteprednol etabonate (Eysuvis) (PDF)  CP.PMN.260  April 1, 2025
Lotilaner (Xdemvy) (PDF) CP.PMN.291 Version effective until March 1, 2026
Lotilaner (Xdemvy) (PDF) CP.PMN.291 March 1, 2026
Lovotibeglogene Autotemcel (Lyfgenia) (PDF)  CP.PHAR.627  Version effective until January 1, 2026
Lovotibeglogene Autotemcel (Lyfgenia) (PDF)  CP.PHAR.627  January 1, 2026
Lubiprostone (Amitiza) (PDF) CP.PMN.142 Version effective until March 1, 2026
Lubiprostone (Amitiza) (PDF) CP.PMN.142 March 1, 2026
Luliconazole Cream (Luzu) (PDF)  CP.PMN.166  April 1, 2025
Lumacaftor-Ivacaftor (Orkambi) (PDF)   CP.PHAR.213   December 1, 2025
Lumasiran (Oxlumo) (PDF)  CP.PHAR.473  April 1, 2025
Lumateperone (Caplyta) (PDF)  CP.PMN.232  January 1, 2026
Lurbinectedin (Zepzelca) (PDF)  CP.PHAR.500  January 1, 2026
Luspatercept-aamt (Reblozyl) (PDF)  CP.PHAR.450  April 1, 2025
Lusutrombopag (Mulpleta)(PDF)  CP.PHAR.407  April 1, 2025
Lutetium Lu 177 dotatate (Lutathera) (PDF)  CP.PHAR.384  October 1, 2025
Lutetium Lu 177 vipivotide tetraxetan (Pluvicto) (PDF)  CP.PHAR.582  July 1, 2025
Macitentan (Opsumit) (PDF)  CP.PHAR.194  April 1, 2025
Mannitol (Bronchitol) (PDF)  CP.PHAR.518  October 1, 2025
Maralixibat (Livmarli) (PDF) CP.PHAR.543  December 1, 2025
Margetuximab-cmkb (Margenza) (PDF)  CP.PHAR.522  April 1, 2025
Maribavir (Livtencity) (PDF)  CP.PMN.271  April 1, 2025
Marstacimab-hncq (Hympavzi) (PDF)  CP.PHAR.674  August 1, 2025
Mavacamten (Camzyos) (PDF)  CP.PMN.272  October 1, 2025
Mavorixafor (Xolremdi)  CP.PHAR.679  July 1, 2025
Mecamylamine (Vecamyl) (PDF)  CP.PMN.136  July 1, 2025
Mecasermin (Increlex) (PDF)  CP.PHAR.150  October 1, 2025
Megestrol Acetate (PDF) CP.PMN.179 December 1, 2025
Melphalan (Hepzato) (PDF) CP.PHAR.653 December 1, 2025
Melphalan flufenamide (Pepaxto) (PDF)  CP.PHAR.535  July 1, 2025
Memantine (Namenda XR, Namzaric) (PDF)  CP.PCH.30  October 1, 2025
Mepolizumab (Nucala) (PDF)  HIM.PA.175  Version effective until January 1, 2026
Mepolizumab (Nucala) (PDF)  HIM.PA.175  January 1, 2026
Mercaptopurine (Purixan) (PDF)    CP.PHAR.447    December 1, 2025
Mechlorethamine (Valchlor) (PDF) CP.PHAR.381 October 1, 2025
Metformin ER (Glumetza, Fortamet) (PDF)  CP.PMN.72  April 1, 2025
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) CP.PHAR.134 Version effective until March 1, 2026
Methotrexate (Otrexup, Rasuvo, Xatmep, Reditrex, Jylamvo) (PDF) CP.PHAR.134 March 1, 2026
Methoxsalen (Uvadex) (PDF) HIM.PA.17 Version effective until March 1, 2026
Methoxsalen (Uvadex) (PDF) HIM.PA.17 March 1, 2026
Methoxy polyethylene glycol-epoetin beta (Mircera) (PDF)  CP.PHAR.238  September 1, 2025
Methylnaltrexone Bromide (Relistor) (PDF) CP.PMN.169 December 1, 2025
Metoclopramide (Gimoti) (PDF) CP.PMN.252 December 1, 2025
Metreleptin (Myalept) (PDF)  CP.PHAR.425  October 1, 2025
Midazolam (Nayzilam) (PDF)  CP.PMN.211  October 1, 2025
Midostaurin (Rydapt) (PDF)  CP.PHAR.344  July 1, 2025
Mifepristone (Korlym) (PDF)  CP.PHAR.101  June 1, 2025
Migalastat (Galafold) (PDF)  CP.PHAR.394  July 1, 2025
Miglustat (Zavesca) (PDF)  CP.PHAR.164  September 1, 2025
Milnacipran (Savella) (PDF)  CP.PMN.125  September 1, 2025
Minocycline ER (Solodyn, Ximino, Minolira), Microspheres (Arestin), Foam (Zilxi) (PDF)    CP.PMN.80   October 1, 2025
Mirdametinib (Gomekli) (PDF) CP.PHAR.718 July 1, 2025
Mirvetuximab soravatansine-gynx (Elahere) (PDF)   CP.PHAR.617  April 1, 2025
Mitapivat (Pyrukynd) (PDF) CP.PHAR.558 December 1, 2025
Mitomycin for Pyelocalyceal Solution (Jelmyto) (PDF)  CP.PHAR.495  December 1, 2025
Mitoxantrone (PDF)  CP.PHAR.258  July 1, 2025
Mixed pollens allergen extract (Oralair) (PDF)  CP.PMN.85  ctober 1, 2025
Mobocertinib (Exkivity) (PDF) CP.PHAR.559 December 1, 2025
Modafinil (Provigil) (PDF)  CP.PMN.39  July 1, 2025
Mogamulizumab-kpkc (Poteligeo) (PDF) CP.PHAR.139 March 1, 2025
Momelotinib (Ojjaara) (PDF) CP.PHAR.654 January 1, 2025
Mometasone (Nasonex) (PDF)  HIM.PA.93  Version effective until March 1, 2026
Mometasone Furoate (Sinuva) (PDF)  CP.PHAR.448  October 1, 2025
Mosunetuzumab-axgb (Lunsumio) (PDF)  CP.PHAR.618  April 1, 2025
Motixafortide (Aphexda) (PDF) CP.PHAR.655 Version effective until March 1, 2026
Motixafortide (Aphexda) (PDF) CP.PHAR.655 March 1, 2026
Moxetumomab pasudotox-tdfk (Lumoxiti) (PDF) CP.PHAR.398 Version effective until March 1, 2026
Nabumatone Double-Strength (Relafen DS) (PDF)   CP.PMN.287   October 1, 2025
Nadofaragene Firadenovec-vncg (Adstiladrin) (PDF) CP.PHAR.461 December 1, 2025
Nafarelin acetate (Synarel®) (PDF)  CP.PHAR.174  July 1, 2025
Naldemedine (Symproic) (PDF) CP.PMN.112 December 1, 2025
Nalmefene (Opvee, Zurnai) (PDF)  CP.PHAR.638  October 1, 2025
Naloxegol (Movantik) (PDF) HIM.PA.167 December 1, 2025
Naproxen/Esomeprazole (Vimovo) (PDF)  CP.PMN.117  October 1, 2025
Naproxen oral suspension (Naprosyn) (PDF) HIM.PA.130 December 1, 2025
Natalizumab (Tysabri) (PDF)  CP.PHAR.259  Version effective until March 1, 2026
Natalizumab (Tysabri) (PDF)  CP.PHAR.259  CP.PHAR.259
Naxitamab-gqgk (Danyelza) (PDF)  CP.PHAR.523  April 1, 2025
Necitumumab (Portrazza) (PDF) CP.PHAR.320 December 1, 2025
Nedosiran (Rivfloza) (PDF)   CP.PHAR.619   September 1, 2025
Nemolizumab-ito (Nemluvio) (PDF)  CP.PHAR.703  Version effctive until March 1, 2026
Nemolizumab-ito (Nemluvio) (PDF)  CP.PCH.59 March 1, 2026
Neomycin/Fluocinolone Cream (Neo-Synalar) (PDF) CP.PMN.167 December 1, 2025
Nerandomilast (Jascayd) (PDF) CP.PHAR.759 January 1, 2026
Neratinib (Nerlynx) (PDF) CP.PHAR.365 Version effective until March 1, 2026
Neratinib (Nerlynx) (PDF) CP.PHAR.365 March 1, 2026
Netupitant and Palonosetron (Akynzeo) (PDF)  CP.PMN.158  October 1, 2025
Nifurtimox (Lampit)  (PDF) CP.PMN.256 December 1, 2025
Nilotinib (Tasigna, Danziten) (PDF)  CP.PHAR.76  July 1, 2025
Nintedanib (Ofev) (PDF) CP.PCH.54 October 1, 2025
Nipocalimab-aahu (Imaavy) (PDF)  CP.PHAR.720  November 1, 2025
Niraparib (Zejula) (PDF)   CP.PHAR.408   December 1, 2025
Niraparib and Abiraterone (Akeega) (PDF) CP.PHAR.645 December 1, 2025
Nirmatrelvir-Ritonavir (Paxlovid) (PDF)  CP.PMN.288  October 1, 2025
Nirogacestat (Ogsiveo) (PDF)  CP.PHAR.671  April 1, 2025
Nirsevimab-alip (Beyfortus) (PDF)  CP.PHAR.614  October 1, 2025
Nitazoxanide (Alinia) (PDF) HIM.PA.152 December 1, 2025
Nitisinone (Nityr, Orfadin) (PDF)  CP.PHAR.132  December 1, 2025
Nivolumab, Nivolumab Hyaluronidase-nvhy (Opdivo, Opdivo Qvantig) (PDF)  CP.PHAR.121   December 1, 2025
Nivolumab and Relatlimab-rmbw (Opdualag) (PDF)  CP.PHAR.588  October 1, 2025
No Coverage Criteria, Recent Label Changes Pending Clinical Policy Update (PDF) HIM.PA.33 December 1, 2025
Nogapendekin alfa inbakicept-pmln (Anktiva) (PDF)  CP.PHAR.684  October 1, 2025
Non-Calcium Phosphate Binders (Auryxia, Fosrenol, Renagel, Renvela, Velphoro) (PDF)   CP.PMN.04  December 1, 2025
Non-Formulary and Formulary Contraceptives (PDF)  HIM.PA.100  July 1, 2025
Non-Formulary Test Strips (PDF)  HIM.PA.34  April 1, 2025
Nusinersen (Spinraza) (PDF)   CP.PHAR.327   October 1, 2025
Obecabtagene autoleucel (Aucatzyl) (PDF)  CP.PHAR.675  Version effective until January 1, 2026
Obecabtagene autoleucel (Aucatzyl) (PDF)  CP.PHAR.675  January 1, 2026
Obeticholic acid (Ocaliva) (PDF)  CP.PHAR.287  December 1, 2025
Obinutuzumab (Gazyva) (PDF) CP.PHAR.305 Version effective until March 1, 2026
Obinutuzumab (Gazyva) (PDF) CP.PHAR.305 March 1, 2026
Ocrelizumab (Ocrevus) (PDF)   CP.PHAR.335   October 1, 2025
Octreotide Acetate (Sandostatin, Sandostatin LAR Depot, Bynfezia, Mycapssa) (PDF)   CP.PHAR.40  June 1, 2025
Odevixibat (Bylvay) (PDF)   CP.PHAR.528   November 1, 2025
Ofatumumab (Arzerra, Kesimpta) (PDF)  CP.PHAR.306  October 1, 2025
Off-Label Drug Use (PDF) HIM.PA.154 December 1, 2025
Olanzapine Long-Acting Injection (Zyprexa Relprevv) (PDF)   CP.PHAR.292  October 1, 2025
Olanzapine-samidorphan (Lybalvi) (PDF)  CP.PMN.265  October 1, 2025
Olaparib (Lynparza) (PDF)  CP.PHAR.360  April 1, 2025
Olezarsen (Tryngolza) (PDF)  CP.PHAR.689  October 1, 2025
Olipudase Alfa-rpcp (Xenpozyme) (PDF)  CP.PHAR.586  October 1, 2025
Olutasidenib (Rezlidhia) (PDF)  CP.PHAR.615  April 1, 2025
Omacetaxine (Synribo) (PDF)  CP.PHAR.108  September 1, 2025
Omadacycline (Nuzyra) (PDF)  CP.PMN.188  October 1, 2025
Omalizumab (Xolair) (PDF)  CP.PCH.49  November 1, 2025
Omaveloxolone (Skyclarys) (PDF)  CP.PHAR.590  July 1, 2025
OnabotulinumtoxinA (Botox) (PDF)   CP.PHAR.232  October 1, 2025
Onasemnogene Abeparvovec (Zolgensma) (PDF)  CP.PHAR.421  Version effective until January 1, 2026
Onasemnogene Abeparvovec (Zolgensma) (PDF)  CP.PHAR.421  January 1, 2026
Ophthalmic Corticosteroids (PDF) HIM.PA.03 Version effective until March 1, 2026
Ophthalmic Corticosteroids (PDF) HIM.PA.03 March 1, 2026
Ophthalmic Riboflavin (Photrexa, Photrexa Viscous) (PDF)  CP.PHAR.536  July 1, 2025
Opicapone (Ongentys) (PDF)  CP.PMN.245  October 2025
Opioid Analgesics (PDF)   HIM.PA.139   Version effective until February 1, 2026
Opioid Analgesics (PDF)   HIM.PA.139   February 1, 2026
Osilodrostat (Isturisa) (PDF)  CP.PHAR.487  October 1, 2025
Osimertinib (Tagrisso) (PDF)  CP.PHAR.294  July 1, 2025
Ospemifene (Osphena) (PDF) CP.PMN.168 December 1, 2025
Overactive Bladder Agents (PDF)   CP.PMN.198   September 1, 2025
Oxymetazoline (Rhofade, Upneeq) (PDF)   CP.PMN.86   October 1, 2025
Ozanimod (Zeposia) (PDF)   CP.PHAR.462   Version effective until March 1, 2026
Ozanimod (Zeposia) (PDF)   CP.PHAR.462   March 1, 2026
Ozenoxacin (Xepi) (PDF)   CP.PMN.119   October 1, 2025
Paclitaxel, Protein-Bound (Abraxane) (PDF)    CP.PHAR.176   October 1, 2025
Pacritinib (Vonjo) (PDF)  CP.PHAR.583  July 1, 2025
Palbociclib (Ibrance) (PDF) HIM.PA.173 Version effective until March 1, 2026
Palbociclib (Ibrance) (PDF) HIM.PA.173 March 1, 2026
Paliperidone Long-Acting Injections (Invega Hafyera, Invega Sustenna, Invega Trinza) (PDF)   CP.PHAR.291  October 1, 2025
Palivizumab (Synagis) (PDF)   CP.PHAR.16 October 1, 2025
Palopegteriparatide (Yorvipath) (PDF) CP.PHAR.696 December 1, 2025
Palovarotene (PDF)  CP.PHAR.548  October 1, 2025
Paltusotide (Palsonify) (PDF) CP.PHAR.755 December 1, 2025
Pancrelipase (Creon, Pancreaze, Pertzye, Viokace, Zenpep) (PDF) CP.PCH.44 December 1, 2025
Panitumumab (Vectibix) (PDF)  CP.PHAR.321  Version effective until March 1, 2026
Panitumumab (Vectibix) (PDF)  CP.PHAR.321  March 1, 2026
Parathyroid Hormone (Natpara) (PDF)  CP.PHAR.282  April 1, 2025
Paricalcitol Injection (Zemplar) (PDF)  CP.PHAR.270  October 1, 2025
Pasireotide (Signifor, Signifor LAR) (PDF) CP.PHAR.332 December 1, 2025
Patiromer (Veltassa) (PDF)  CP.PMN.205  October 1, 2025
Patisiran (Onpattro) (PDF)  CP.PHAR.395  July 1, 2025
Pazopanib (Votrient) (PDF)  CP.PHAR.81  December 1, 2025
Peanut allergen powder (Palforzia) (PDF)  CP.PMN.220  October 1, 2025
Pegaspargase (Oncaspar), Calaspargase Pegol-mknl (Asparlas) (PDF) CP.PHAR.353 December 1, 2025
Pegcetacoplan (Empaveli, APL-2) (PDF)   CP.PHAR.524  December 1, 2025
Pegfilgrastim/Biosimilars, Eflapegrastim, Efbemalenograstim (PDF)  CP.PHAR.296  October 1, 2025
Peginterferon Alfa-2a (Pegasys) (PDF) CP.PHAR.89 Version erffective until December 1, 2025
Peginterferon Alfa-2a (Pegasys) (PDF)  CP.PHAR.89  December 1, 2025
Peginterferon beta-1a (Plegridy) (PDF)  CP.PHAR.271  July 1, 2025
Pegloticase (Krystexxa) (PDF)  CP.PHAR.115  April 1, 2025
Pegunigalsidase Alfa-iwxj (Elfabrio) (PDF)  CP.PHAR.512  September 1, 2025
Pegvaliase-pqpz (Palynziq) (PDF) CP.PHAR.140 Version effective until March 1, 2026
Pegvaliase-pqpz (Palynziq) (PDF) CP.PHAR.140 March 1, 2026
Pegvisomant (Somavert) (PDF) CP.PHAR.389 December 1, 2025
Pembrolizumab (Keytruda®) (PDF)   CP.PHAR.322   Version effective until February 1, 2026
Pembrolizumab (Keytruda®) (PDF)   CP.PHAR.322   February 1, 2026
Pemetrexed (Alimta, Pemfexy, Axtle) (PDF)  CP.PHAR.368 December 1, 2025
Pemigatinib (Pemazyre) (PDF) CP.PHAR.496 Version effectice until December 1, 2025
Pemigatinib (Pemazyre) (PDF)  CP.PHAR.496  December 1, 2025
Penicillamine (Cuprimine) (PDF) CP.PCH.09 December 1, 2025
Penpulimab-kcqx (PDF) CP.PHAR.732 October 1, 2025
Perampanel (Fycompa) (PDF)  CP.PMN.156  Version effective until January 1, 2026
Perampanel (Fycompa) (PDF)  CP.PMN.156  January 1, 2026
Perfluorohexyloctane (Miebo) (PDF)  CP.PMN.290  October 1, 2025
Pertuzumab (Perjeta, Poherdy) (PDF)  CP.PHAR.227  January 1, 2026
Pertuzumab/Trastuzumab/Hyaluronidase-zzxf (Phesgo) (PDF)   CP.PHAR.501  October 1, 2025
Pexidartinib (Turalio)(PDF) CP.PHAR.436 December 1, 2025
Phendimetrazine (PDF)  CP.PCH.47  July 1, 2025
Phentermine (Adipex-P, Lomaira) (PDF)  CP.PCH.13  July 1, 2025
Pilocarpine (Vuity) (PDF) CP.PMN.270 Version effective until March 1, 2026
Pilocarpine (Vuity) (PDF) CP.PMN.270 March 1, 2026
Pimavanserin (Nuplazid) (PDF)  CP.PMN.140  October 1, 2025
Pirfenidone (Esbriet) (PDF)   CP.PHAR.286   October 1, 2025
Pirtobrutinib (Jaypirca) (PDF)  CP.PHAR.620  July 1, 2025
Pitolisant (Wakix) (PDF)   CP.PMN.221   October 1, 2025
Plasminogen, human-tvmh (Ryplazim) (PDF) CP.PHAR.513 December 1, 2025
Plecanatide (Trulance) (PDF) CP.PMN.87 January 1, 2025
Plerixafor (Mozobil) (PDF)   CP.PHAR.323  October 1, 2025
Polatuzumab Vedotin-piiq (Polivy) (PDF)  CP.PHAR.433  December 1, 2025
Pomalidomide (Pomalyst) (PDF)  CP.PHAR.116  Version effective until March 1, 2026
Pomalidomide (Pomalyst) (PDF)  CP.PHAR.116  March 1, 2026
Ponatinib (Iclusig) (PDF)  CP.PHAR.112  July 1, 2025
Ponesimod (Ponvory) (PDF)   CP.PHAR.537   October 1, 2025
Potassium Chloride for Oral Solution (Klor-Con Powder) (PDF)  HIM.PA.143  April 1, 2025
Pozelimab-bbfg (Veopoz) (PDF)  CP.PHAR.626  September 1, 2025
Prademagene Zamikeracel (Zevaskyn) (PDF) CP.PHAR.609 Version effective until January 1, 2026
Prademagene Zamikeracel (Zevaskyn) (PDF) CP.PHAR.609 January 1, 2026
Pralatrexate (Folotyn) (PDF) CP.PHAR.313 Version effective until March 1, 2026
Pralatrexate (Folotyn) (PDF) CP.PHAR.313 March 1, 2026
Pramlintide (Symlin) (PDF)  CP.PMN.129  April 1, 2025
Prasterone (Intrarosa) (PDF)  CP.PMN.99  December 1, 2025
Pregabalin (Lyrica) (PDF)  CP.PMN.33  Version effective until January 1, 2026
Pregabalin (Lyrica) (PDF)  CP.PMN.33  January 1, 2026
Pretomanid (PDF)  CP.PMN.222  April 1, 2025
Progesterone (Crinone, Endometrin, Milprosa) (PDF)  CP.PMN.243  October 1, 2025
Propranolol (Hemangeol) (PDF)  CP.PCH.51  July 1, 2025
Protein C Concentrate, Human (Ceprotin) (PDF)  CP.PHAR.330  April 1, 2025
Prucalopride (Motegrity) (PDF)  HIM.PA.159  December 1, 2025
Pyrimethamine (Daraprim®) (PDF)  CP.PMN.44  December 1, 2025
Quantity Limit Override and Dose Optimization (PDF) CP.PMN.59 Version effective until March 1, 2026
Quantity Limit Override and Dose Optimization (PDF) CP.PMN.59 March 1, 2026
Quetiapine ER (Seroquel XR) (PDF)  CP.PMN.64  April 1, 2025
Quinine Sulfate (Qualaquin) (PDF)   CP.PMN.262   October 1, 2025
Quizartinib (Vanflyta) (PDF) CP.PHAR.646 Version effective until March 1, 2026
Quizartinib (Vanflyta) (PDF) CP.PHAR.646 March 1, 2026
Ramucirumab (Cyramza) (PDF)  CP.PHAR.119  July 1, 2025
Ranibizumab (Lucentis, Susvimo), Lucentis Biosimilars (PDF)    CP.PHAR.186    August 1, 2025
Rasagiline (Azilect®) (PDF)  HIM.PA.89  October 1, 2025
Ravulizumab-cwvz (Ultomiris) (PDF)   CP.PHAR.415  December 1, 2025
Regorafenib (Stivarga) (PDF)  CP.PHAR.107  July 1, 2025
Relugolix (Orgovyx), Relugolix/Estradiol/Norethinedrone (Myfembree) (PDF)   CP.PHAR.529   October 1, 2025
Remestemcel-L (Ryoncil) (PDF)  CP.PHAR.474  Version effective until January 1, 2026
Remestemcel-L-rknd (Ryoncil) (PDF)  CP.PHAR.474  January 1, 2026
Remetirom (Rezdiffra) (PDF) CP.PHAR.647 Version effective until March 1, 2026
Remetirom (Rezdiffra) (PDF) CP.PHAR.647 March 1, 2026
Remibrutinib (Rhapsido) (PDF) CP.PHAR.756 December 1, 2025
Repository Corticotropin Injection (H.P. Acthar Gel, Purified Cortrophin Gel) (PDF)    HIM.PA.168   October 1, 2025
Repotrectinib (Augtyro) (PDF)  CP.PHAR.667  April 1, 2025
Reslizumab (Cinqair) (PDF)  CP.PHAR.223  April 1, 2025
Respiratory syncytial virus vaccine (Abrysvo) (PDF) CP.PHAR.658 January 1, 2025
Retifanlimab-dlwr (Zynyz) (PDF)   CP.PHAR.629   August 1, 2025
Revakinagene Taroretcel-lwey (Encelto) (PDF) CP.PHAR.697 Version effective until January 1, 2026
Revakinagene Taroretcel-lwey (Encelto) (PDF) CP.PHAR.697 January 1, 2026
Revumenib (Revuforj) (PDF) CP.PHAR.707 April 1, 2025
Ribavirin (Copegus, Moderiba, Rebetol, Ribasphere) (PDF) CP.PHAR.141 December 1, 2025
Ribociclib (Kisqali, Kisqali Femara) (PDF) CP.PHAR.334 December 1, 2025
Rifabutin (Mycobutin) (PDF)  CP.PMN.223  December 1, 2025
Rifamycin (Aemcolo) (PDF)   CP.PMN.196   October 1, 2025
Rifaximin (Xifaxan®) (PDF) CP.PMN.47 December 1, 2025
Rilonacept (Arcalyst) (PDF)  CP.PHAR.266  September 1, 2025
Rilzabrutinib (Wayrilz) (PDF) CP.PHAR.751 March 1, 2026
RimabotulinumtoxinB (Myobloc) (PDF)   CP.PHAR.233   October 1, 2025
Rimegepant (Nurtec ODT) (PDF) CP.PHAR.490 December 1, 2025
Riociguat (Adempas®) (PDF)  CP.PHAR.195  April 1, 2025
Ripretinib (Qinlock) (PDF)  CP.PHAR.502  October 1, 2025
Risdiplam (Evrysdi) (PDF)  CP.PHAR.477  July 1, 2025
Risedronate (Actonel, Atelvia) (PDF)  CP.PMN.100  December 1, 2025
Risperidone Long-Acting Injection (Perseris, Risperdal Consta, Rykindo, Uzedy) (PDF)   CP.PHAR.293  December 1, 2025
Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) (PDF)    CP.PHAR.260   Version effective until March 1, 2026
Rituximab (Rituxan, Riabni, Ruxience, Truxima, Rituxan Hycela) (PDF)    CP.PHAR.260   March 1, 2026
Roflumilast (Daliresp, Zoryve) (PDF)  CP.PMN.46  December 1, 2025
Rolapitant (Varubi) (PDF)  CP.PMN.102  October 1, 2025
Romidepsin (Istodax) (PDF) CP.PHAR.314 December 1, 2025
Romiplostim (Nplate) (PDF)  CP.PHAR.179  Version effective until January 1, 2026
Romiplostim (Nplate) (PDF)  CP.PHAR.179  January 1, 2026
Romosozumab-aqqg (Evenity) (PDF)   CP.PHAR.428   December 1, 2025
Ropeginterferon Alfa-2b-njft (BESREMi) (PDF)  CP.PHAR.570  April 1, 2025
Rozanolixizumab-noli (Rystiggo) (PDF) CP.PHAR.648 Version effective until March 1, 2026
Rozanolixizumab-noli (Rystiggo) (PDF) CP.PHAR.648 March 1, 2026
Rucaparib (Rubraca®) (PDF)  CP.PHAR.350  April 1, 2025
Rufinamide (Banzel) (PDF)  CP.PMN.157  December 1, 2025
Ruxolitinib (Jakafi) (PDF)  CP.PHAR.98  Version effective until February 1, 2026
Ruxolitinib (Jakafi) (PDF)  CP.PHAR.98  February 1, 2026
Sacituzumab Govitecan-hziy (Trodelvy) (PDF)  CP.PHAR.475  July 1, 2025
Sacubitril/Valsartan (Entresto) (PDF)  CP.PCH.52  Version effective until March 1, 2026
Safinamide (Xadago) (PDF)  CP.PMN.113  April 1, 2025
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF)  CP.PHAR.43  Version effective until March 1, 2026
Sapropterin Dihydrochloride (Kuvan, Javygtor) (PDF)  CP.PHAR.43  March 1, 2026
Sarecycline (Seysara) (PDF)  CP.PMN.189  April 1, 2025
Sargramostim (Leukine) (PDF)  CP.PHAR.295  December 1, 2025
Satralizumab-mwge (Enspryng) (PDF)   CP.PHAR.463  December 1, 2025
Sebelipase Alfa (Kanuma) (PDF)  CP.PHAR.159  July 1, 2025
Sebetralstat (Ekterly) (PDF)  CP.PHAR.723  November 1, 2025
Secnidazole (Solosec) (PDF)  CP.PMN.103  April 1, 2025
Seladelpar (Livdelzi) (PDF) CP.PHAR.698 December 1, 2025
Selexipag (Uptravi®) (PDF)  CP.PHAR.196  April 1, 2025
Selinexor (Xpovio) (PDF)  CP.PHAR.431  October 1, 2025
Selpercatinib (Retevmo) (PDF)  CP.PHAR.478  July 1, 2025
Selumetinib (Koselugo) (PDF)  CP.PHAR.464  Version effective until February 1, 2026
Selumetinib (Koselugo) (PDF)  CP.PHAR.464  February 1, 2026
Semaglutide (Wegovy) (PDF)   CP.PMN.295   Version effective until March 1, 2026
Semaglutide (Wegovy) (PDF)   CP.PMN.295   March 1, 2026
Semaglutide (Wegovy) - FEHB Members Only (PDF) QR.QC.CP.352 Version effective until January 1, 2026
Semaglutide (Wegovy) - FEHB Members Only (PDF) QR.QC.CP.352 January 1, 2026
Sepiapterin (Sephience) CP.PHAR.708 November 1, 2025
Sepsis Diagnosis (PDF) CC.PP.073 November 1, 2024
Setmelanotide (Imcivree) (PDF)  CP.PHAR.491  July 1, 2025
Short ragweed pollen allergen extract (Ragwitek) (PDF)  CP.PMN.83  October 1, 2025
Sildenafil (Revatio®) (PDF)  CP.PHAR.197  April 1, 2025
Sildenafil (Viagra) (PDF)  CP.PCH.07  July 1, 2025
Siltuximab (Sylvant) (PDF)  CP.PHAR.329  April 1, 2025
Siponimod (Mayzent) (PDF)   CP.PHAR.427   October 1, 2025
Sirolimus Protein-Bound Particles (Fyarro), Topical Gel (Hyftor) (PDF)   CP.PHAR.574  April 1, 2025
Sodium Oxybate (Xyrem, Lumryz) and Calcium Magnesium Potassium Sodium Oxybate (Xywav) (PDF)    CP.PMN.42   October 1, 2025
Sodium Phenylbutyrate (Buphenyl) (PDF)  CP.PHAR.208  April 1, 2025
Sodium Phenylbutyrate-Taurursodiol (Relyvrio) (PDF)  CP.PHAR.584  July 1, 2025
Sodium thiosulfate (Pedmark) (PDF)  CP.PHAR.610  April 1, 2025
Sodium Zirconium Cyclosilicate (Lokelma) (PDF)  CP.PMN.163  October 1, 2025
Sodium-Glucose Co-Transporter 2 Inhibitors (PDF)  HIM.PA.91  April 1, 2025
Sofosbuvir (Sovaldi) (PDF)  HIM.PA.SP2  December 1, 2025
Sofosbuvir-Vepatasvir-Voxilaprevir (Vosevi) (PDF)  HIM.PA.SP63  December 1, 2025
Solriamfetol (Sunosi) (PDF)  CP.PMN.209  September 1, 2025
Sonidegib (Odomzo) (PDF)  CP.PHAR.272  July 1, 2025
Sorafenib (Nexavar) (PDF)  CP.PHAR.69  September 1, 2025
Sotatercept (ACE-011) (PDF)  CP.PHAR.657  April 1, 2025
Sotorasib (Lumakras) (PDF)   CP.PHAR.549   October 1, 2025
Sparsentan (Filspari) (PDF)   CP.PHAR.631   October 1, 2025
Spesolimab-sbzo (Spevigo) (PDF)  CP.PHAR.606  October 1, 2025
Spinosad (Natroba) (PDF)  HIM.PA.134  October 1, 2025
Step Therapy Criteria (PDF)  HIM.PA.109  Version effective until January 1, 2026
Step Therapy Criteria (PDF)  HIM.PA.109  January 1, 2026
Stiripentol (Diacomit) (PDF) CP.PMN.184 December 1, 2025
Sunitinib (Sutent) (PDF)  CP.PHAR.73  September 1, 2025
Sunvozertinib (Zegfrovy) (PDF) CP.PHAR.742 October 1, 2025
Sutimlimab-jome (Enjaymo) (PDF)  CP.PHAR.503  July 1, 2025
Suvorexant (Belsomra®) (PDF) CP.PMN.109 December 1, 2025
Suzetrigine (Journavx) (PDF)  CP.PMN.301  October 1, 2025
Tadalafil (Adcirca®) (PDF)  CP.PHAR.198  April 1, 2025
Tadalafil BHP - ED (Cialis) (PDF)  CP.PMN.132  October 1, 2025
Tafamidis (Vyndaqel, Vyndamax) (PDF)   CP.PHAR.432   October 1, 2025
Tafasitamab-cxix (Monjuvi) (PDF)  CP.PHAR.508  December 1, 2025
Talazoparib (Talzenna)(PDF)  CP.PHAR.409  April 1, 2025
Taletrectinib (Ibtrozi) (PDF) CP.PHAR.740 October 1, 2025
Taliglucerase Alfa (Elelyso) (PDF)   CP.PHAR.157   October 1, 2025
Talimogene laherepvec (Imlygic) (PDF)  CP.PHAR.542  October 1, 2025
Talquetamab-tgvs (Talvey) (PDF) CP.PHAR.649 Version effective until March 1, 2026
Talquetamab-tgvs (Talvey) (PDF) CP.PHAR.649 March 1, 2026
Tapinarof (Vtama) (PDF)  CP.PMN.283  December 1, 2025
Tarlatamab-dlle (Imdelltra) (PDF)  CP.PHAR.685  January 1, 2026
Tasimelteon (Hetlioz) (PDF)  CP.PMN.104  December 1, 2025
Tavaborole (Kerydin®) (PDF)  CP.PMN.105  April 1, 2025
Tazarotene (Arazlo, Fabior, Tazorac) (PDF) CP.PMN.244 December 1, 2025
Tazemetostat (PDF)  CP.PHAR.452  April 1, 2025
Tebentafusp-tebn (Kimmtrak) (PDF)  CP.PHAR.575  July 1, 2025
Teclistamab-cqyv (Tecvayli) (PDF)  CP.PHAR.611  April 1, 2025
Tedizolid (Sivextro) (PDF)  CP.PMN.62  October 1, 2025
Teduglutide (Gattex) (PDF)  CP.PHAR.114  April 1, 2025
Telisotuzumab Vedotin-tllv (Emrelis) (PDF)  CP.PHAR.733  November 1, 2025
Telotristat Ethyl (Xermelo) (PDF)   CP.PHAR.337   October 1, 2025
Temozolomide (Temodar) (PDF)  CP.PHAR.77  September 1, 2025
Temsirolimus (Torisel) (PDF) CP.PHAR.324 December 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)  CP.PMN.224  October 1, 2025
Tenapanor (Ibsrela, Xphozah) (PDF)   HIM.PA.174   July 1, 2025
Tenofovir Alafenamide Fumarate (Vemlidy) (PDF)  CP.PMN.268  December 1, 2025
Teplizumab-mzwv (Tzield) (PDF)  CP.PHAR.492  April 1, 2025
Tepotinib (Tepmetko) (PDF)  CP.PHAR.530  July 1, 2025
Teprotumumab (Tepezza) (PDF)  CP.PHAR.465  December 1, 2025
Teriflunomide (Aubagio) (PDF)  CP.PCH.40  July 1, 2025
Teriparatide (Forteo®) (PDF)   CP.PHAR.188   October 1, 2025
Tesamorelin (Egrifta) (PDF)  CP.PHAR.109  October 1, 2025
Testosterone (Androderm) (PDF)  HIM.PA.87  December 1, 2025
Testosterone (Testopel, Jatenzo, Kyzatrex, Tlando) (PDF)   CP.PHAR.354  December 1, 2025
Tetrabenazine (Xenazine) (PDF)  CP.PHAR.92  July 1, 2025
Tezacaftor-Ivacaftor (Symdeko) (PDF)  CP.PHAR.377  December 1, 2025
Tezepelumab-ekko (Tezspire) (PDF) CP.PHAR.576 Version effective until March 1, 2026
Tezepelumab-ekko (Tezspire) (PDF) HIM.PA.176 Version effective until March 1, 2026
Tezepelumab-ekko (Tezspire) (PDF) HIM.PA.176 March 1, 2026
Thalidomide (Thalomid) (PDF)   CP.PHAR.78   October 1, 2025
Thioguanine (Tabloid) (PDF) CP.PHAR.437 Version effective until March 1, 2026
Thioguanine (Tabloid) (PDF) CP.PHAR.437 March 1, 2026
Thyrotropin alfa (Thyrogen) (PDF)  CP.PHAR.95  October 1, 2025
Timothy grass pollen allergen extract (Grastek®) (PDF)  CP.PMN.84  October 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF)  CP.PCH.50  July 1, 2025
Tiopronin Delayed-Release (Thiola EC) (PDF)  CP.PHAR.725 Version effective until January 1, 2026
Tiopronin Delayed-Release (Thiola EC) (PDF)  CP.PHAR.725 January 1, 2026
Tirzepatide (Zepbound) (PDF)  CP.PMN.298  Version effective until March 1, 2026
Tirzepatide (Zepbound) (PDF)  CP.PMN.298  March 1, 2026
Tisagenlecleucel (Kymriah) (PDF)  CP.PHAR.361  Version effective until January 1, 2026
Tisagenlecleucel (Kymriah) (PDF)  CP.PHAR.361  January 1, 2026
Tislelizumab-jsgr (Tevimbra) (PDF)   CP.PHAR.687   October 1, 2025
Tisotumab Vedotin-tftv (Tivdak) (PDF) CP.PHAR.561 Version effective until March 1, 2026
Tisotumab Vedotin-tftv (Tivdak) (PDF) CP.PHAR.561 March 1, 2026
Tivozanib (Fotivda) (PDF)  CP.PHAR.538  July 1, 2025
Tobramycin (PDF)  CP.PHAR.211  October 1, 2025
Tofersen (Qalsody) (PDF) CP.PHAR.591 Version effective until March 1, 2026
Tofersen (Qalsody) (PDF) CP.PHAR.591 March 1, 2026
Tolvaptan (Jynarque) (PDF)  CP.PHAR.27  December 1, 2025
Topical Acne Treatment (PDF) HIM.PA.71 December 1, 2025
Topical Immunomodulators (PDF)  CP.PMN.107  April 1, 2025
Topiramate ER (Qudexy XR, Trokendi XR (PDF)  CP.PMN.281  December 1, 2025
Topotecan (Hycamtin) (PDF)  CP.PHAR.64  July 1, 2025
Toripalimab (Loqtorzi) (PDF)  CP.PHAR.668  April 1, 2025
Tovorafenib (Ojemda) (PDF)  CP.PHAR.686  October 1, 2025
Trabectedin (Yondelis) (PDF)  CP.PHAR.204  April 1, 2025
Tralokinumab-ldrm (Adbry) (PDF)  CP.PHAR.577  Version effective until March 1, 2026
Tralokinumab-ldrm (Adbry) (PDF)  CP.PCH.60 March 1, 2026
Trametinib (Mekinist) (PDF)  CP.PHAR.240  July 1, 2025
Trastuzumab/Biosimilars, Trastuzumab-Hyaluronidase (PDF)    CP.PHAR.228   August 1, 2025
Travoprost (iDose TR) (PDF)  CP.PHAR.672  April 1, 2025
Tremelimumab-actl (Imjudo) (PDF)  CP.PHAR.612  June 1, 2025
Treprostinil (Orenitram®, Remodulin®, Tyvaso®) (PDF)    CP.PHAR.199    November 1, 2025
Triamcinolone ER Injection (Zilretta) (PDF)  CP.PHAR.371  December 1, 2025
Triclabendazole (Egaten) (PDF)  CP.PMN.207  October 1, 2025
Trientine (Syprine) (PDF) CP.PHAR.438 Version effective until March 1, 2026
Trientine (Syprine) (PDF) CP.PHAR.438 March 1, 2026
Trifarotene (Aklief) (PDF)  CP.PMN.225  April 1, 2025
Trifluridine/Tipiracil (Lonsurf) (PDF)  CP.PHAR.383  October 1, 2025
Triheptanoin (Dojolvi) (PDF) CP.PHAR.509 December 1, 2025
Triptorelin Pamoate (Trelstar, Triptodur) (PDF)  CP.PHAR.175  Version effective until March 1, 2026
Triptorelin Pamoate (Trelstar, Triptodur) (PDF)  CP.PHAR.175  March 1, 2026
Trofinetide (Daybue) (PDF)  CP.PHAR.600  July 1, 2025
Tucatinib (Tukysa) (PDF)  CP.PHAR.497  October 1, 2025
Ublituximab-xiiy (Briumvi) (PDF)   CP.PHAR.621   October 1, 2025
Ulcer Therapy Products (Omeclamox Pak, Pylera, Talicia, Voquezna) (PDF)   CP.PMN.277   October 1, 2025
Umbralisib (Ukoniq) (PDF)  CP.PHAR.531  July 1, 2025
Uridine acetate (Vistogard) (PDF) HIM.PA.SP55 December 1, 2025
Vadadustat (Vafseo) (PDF)  CP.PHAR.677  September 1, 2025
Valbenazine (Ingrezza) (PDF)  CP.PCH.48  Version effective until January 1, 2026
Valbenazine (Ingrezza, Ingrezza Sprinkle) (PDF)  CP.PHAR.340 January 1, 2026
Valganciclovir (Valcyte) (PDF)  CP.PCH.06  April 1, 2025
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF)   CP.PHAR.466   Version effective until January 1, 2026
Valoctocogene Roxaparvovec-rvox (Roctavian) (PDF)   CP.PHAR.466   January 1, 2026
Valrubicin (Valstar) (PDF) CP.PHAR.439 Version effective until March 1, 2026
Valrubicin (Valstar) (PDF) CP.PHAR.439 March 1, 2026
Vamorolone (Agamree) (PDF)  CP.PHAR.659  April 1, 2025
Vandetanib (Caprelsa®) (PDF)  CP.PHAR.80  April 1, 2025
Vanzacaftor/Tezacaftor/Deutivacaftor (Alyftrek) (PDF)  CP.PHAR.700  December 1, 2025
Varenicline (Tyrvaya) (PDF)  CP.PMN.273  April 1, 2025
Velaglucerase Alfa (VPRIV) (PDF)   CP.PHAR.163   October 1, 2025
Velmanase Alfa-tycv (Lamzede) (PDF)  CP.PHAR.601  July 1, 2025
Velpatasvir (Epclusa) (PDF)  HIM.PA.SP1  December 1, 2025
Vemurafenib (Zelboraf®) (PDF)  CP.PHAR.91  June 1, 2025
Venetoclax (Venclexta) (PDF) CP.PHAR.129 Version effective until March 1, 2026
Venetoclax (Venclexta) (PDF) CP.PHAR.129 March 1, 2026
Verteporfin (Visudyne) (PDF)  CP.PHAR.187  April 1, 2025
Vestronidase Alfa-vjbk (Mepsevii) (PDF)  CP.PHAR.374  July 1, 2025
Vigabatrin (Sabril) (PDF)  CP.PHAR.169  December 1, 2025
Viloxazine (Qelbree) (PDF)   CP.PMN.264   November 1, 2025
Viltolarsen (Viltepso) (PDF)  CP.PHAR.484  April 1, 2025
Vimseltinib (Romvimza) (PDF) CP.PHAR.726 July 1, 2025
Vismodegib (Erivedge) (PDF)  CP.PHAR.273  July 1, 2025
Voclosporin (Lupkynis) (PDF)  CP.PHAR.504  July 1, 2025
Vorapaxar (Zontivity) (PDF)  HIM.PA.146  April 1, 2025
Vorasidenib (Voranigo) (PDF) CP.PHAR.699 Version effective until March 1, 2026
Vorasidenib (Voranigo) (PDF) CP.PHAR.699 March 1, 2026
Voretigene Neparvovec-rzyl (Luxturna) (PDF)  CP.PHAR.372  Version effective until January 1, 2026
Voretigene Neparvovec-rzyl (Luxturna) (PDF)  CP.PHAR.372  January 1, 2026
Vorinostat (Zolinza) (PDF)  CP.PHAR.83  October 1, 2025
Vortioxetine (Trintellix®) (PDF)  CP.PMN.65  December 1, 2025
Vosoritide (Voxzogo) (PDF) CP.PHAR.525 April 1, 2025
Voxelotor (Oxbryta) (PDF)  CP.PHAR.451  April 1, 2025
Vutrisiran (Amvuttra)  CP.PHAR.550  July 1, 2025
Xanomeline-trospium chloride (Cobenfy) CP.PMN.299 April 1, 2025
Zanidatamab-hrii (Ziihera) (PDF)  CP.PHAR.709  August 1, 2025
Zanubrutinib (Brukinsa) (PDF)   CP.PHAR.467   October 1, 2025
Zavegepant (Zavzpret) (PDF) CP.PHAR.630 December 1, 2025
Zenocutuzumab-zbco (Bizengri) (PDF)  CP.PHAR.713  August 1, 2025
Zilucoplan (RA101495) (PDF)  CP.PHAR.616  June 1, 2025
Ziv-aflibercept (Zaltrap) (PDF) CP.PHAR.325 December 1, 2025
Zolbetuximab-clzb (Vyloy) (PDF)   CP.PHAR.705   Version effective until March 1, 2026
Zolbetuximab-clzb (Vyloy) (PDF)   CP.PHAR.705   March 1, 2026
Zoledronic Acid (Reclast) (PDF)  CP.PHAR.59  December 1, 2025
Zongertinib (Hernexeos) (PDF) CP.PHAR.750 March 1, 2026
Zopapogene Imadenovec (Papzimeos) (PDF) CP.PHAR.730 Version effective until March 1, 2026
Zopapogene Imadenovec (Papzimeos) (PDF) CP.PHAR.730 March 1, 2026
Zuranolone (Zurzuvae) (PDF)  CP.PHAR.650  July 1, 2025
Evernorth Prior Authorization Statistics
   
Policy Title Policy Number Effective Date
Arkansas Medical Audit Bill of Rights Act Policy (PDF) AR.BO.04 August 5, 2025